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ABSTRACT 
 
FAMILIAL AGGREGATION OF IDEAL CARDIOVASCULAR HEALTH AND 
CARDIOVASCULAR DISEASE DISABILITY-ADJUSTED LIFE YEARS IN PARENT-
OFFSPRING DYADS: ANALYSIS OF THE FRAMINGHAM HEART STUDY 
May 2019 
James M. Muchira, BSN., University of Eastern Africa Baraton 
M.S., University of Massachusetts Boston 
Ph.D., University of Massachusetts Boston 
 
 
Directed by Professor Laura L. Hayman 
 Background: Ideal cardiovascular health (iCVH) is defined as the simultaneous 
presence of seven health metrics-physical activity, not-smoking, healthy diet, healthy body 
weight, and blood cholesterol, blood pressure, and blood glucose levels as defined by 
evidence-based guidelines. Evidence suggests familial aggregation of single cardiovascular 
disease (CVD) risk factors but research on clustering of seven iCVH metrics and CVD 
disability-adjusted life years (CVD DALYs) within families is lacking. 
Purpose: To examine trends and relationship of parental iCVH and offspring iCVH and CVD 
DALYs at similar age across the lifespan.  
Methods: A secondary data analysis of the Framingham Heart Study (FHS) Dataset-Original 
and Offspring Cohorts. Pearson correlations and multivariate linear regressions were used to 
assess linear relationships of iCVH; T-test and chi-square were used to test differences 
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between iCVH metrics and CVD DALYs. Proportional odds model was used for assessing 
relationships of ordered iCVH categories. Brant test and gologit2 command in Stata©14 
were used to test the parallel assumptions of the proportional odds model. CVD disability 
weights were derived from the Global Burden of Disease Study (GBD) 2015 DALYs and 
Health Adjusted Life Expectancy (HALE) Collaborators. 
Results: At total of 2734 parents and 3492 offspring met inclusion criteria with 1,044 distinct 
families with a mean of 2 children per family. Women participants were slightly higher than 
men in both cohorts (p<0.001). Offspring iCVH was positively correlated with the parents 
iCVH (r≤0.25). “Ideal” parental iCVH increased the odds of offspring attaining “ideal” 
iCVH by two-to-fourfold. Offspring of parents with high iCVH had lower mean CVD 
DALYs compared with offspring of parents with lower iCVH. iCVH was inversely 
associated with CVD DALYs. The mean CVD DALYs of Offspring Cohort was 5.5 (95% CI 
5.2-5.9) compared with 1.8 (95% CI 1.6-1.9) in Original Cohort (p<0.001). 
Conclusion: Results indicate familial clustering of iCVH metrics over the lifespan, with 
positive parental-offspring iCVH relationship and inverse relationship of iCVH and CVD 
DALYs. This study fuels the impetus for systems approaches in implementation of family-
based interventions that combine multiple iCVH metrics with the ultimate goal of improving 
cardiovascular health for families and communities. 
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CHAPTER 1 
INTRODUCTION 
 The overall burden of cardiovascular disease (CVD) in the United States has not 
declined despite a reduction in deaths attributable to CVD. An estimated 92.1 million (28%) 
Americans have some form of CVD and about 1 in 3 deaths in the United States is due to 
CVD (American Heart Association [AHA], 2018b; Mozaffarian et al., 2015). Coronary heart 
disease (CHD) is the most prevalent form of CVD and the leading cause of death in the 
United States where it contributes to half of all CVD deaths (Centers for Disease Prevention 
and Control [CDC], 2017). Consequently, CVD leads to increased total loss of economic 
productivity and increased medical costs.  In 2016 for instance, the total annual cost of CVD 
was $555 billion, and is projected to more than double to $1 trillion by 2035 (AHA, 2018a). 
 The AHA 2010 Impact Goals to address CVD morbidity and mortality by 
implementing health behavior modification aim to reduce CVD mortality in United States by 
20% by 2020. These goals have been enumerated in the AHA’s 2020 Impact Goals for 
monitoring Americans’ cardiovascular health (AHA, 2013). The AHA Goals and Metrics 
Committee defined ideal cardiovascular health (iCVH) as simultaneous presence of 
recommended levels of three health behaviors (not smoking cigarettes, physical activity, 
eating healthy diet) and four other health factors (normal body mass index [BMI], blood 
pressure, total cholesterol and blood sugar) [henceforth collectively referred to as iCVH 
metrics] (Lloyd-Jones et al., 2010).  However, extremely few people (<1%) meet all seven 
recommended iCVH metrics, with findings from cardiovascular health studies suggesting 
that only a small fraction (4%) of the American population meet at least five recommended 
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iCVH metrics (Lloyd-Jones et al., 2006). The 2017 AHA statistical data suggested that 17% 
adults meet at least five iCVH metrics and younger adults are expected to attain greater 
proportion of iCVH metrics than older adults (AHA, 2017a). Age and sex-adjusted estimates 
indicate that females tend to achieve more iCVH metrics than males. Poor diet and low 
physical activity largely contribute to the low attainment of iCVH both in children and adults 
(AHA, 2017a). A study of adults without documented CVD using the National Health and 
Nutrition Examination Survey (NHANES) data (1988-2014) showed that iCVH is on the 
decline, with the non-Hispanic whites having the largest decline of up to 15% (Brown et al., 
2018).  
 Measurement of iCVH can be approached from the lens of self-care activities, as 
captured in the AHA Life Simple 7 factors (same as iCVH metrics), since the self-care 
management of CVD targets attainment of all the seven iCVH metrics for prevention of CVD 
and stroke (Riegel et al., 2017; Webber, Guo, & Mann, 2015). Chronic disease self-care is 
rarely quantified by clinicians as it is seen as the individual’s responsibility to self-manage 
their diseases. The AHA recently released a scientific statement of self-care in prevention 
and management of CVD and stroke based on the Life Simple 7 factors that underscores the 
observation that CVD self-care has been ignored for a long time (Riegel et al., 2017). In the 
context of everyday living, the scientific statement authors noted that patient-to-provider 
contact is minimal with only 10 (0.1%) of 8760 hours per year with clinicians. This is a clear 
indicator that people engage in health promotion or management activities in the community 
settings (home, work, recreation) and highlights the need for more attention to empowering 
individuals with self-management strategies during clinician visits. 
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 Familial aggregation is defined as clustering or occurrence of shared exposure to 
diseases within families attributable to genetic, environmental or infectious factors 
(Matthews, Finkelstein, & Betensky, 2008). In this study, a family is viewed in the context of 
a social cultural environment of biologically related parents and children. Familial 
aggregation studies are important to determine if a disease or disorder or certain behaviors 
occur in clusters or shared within families. The burden of CVD can be estimated 
quantitatively using disability-adjusted life years (DALYs) measure. Disability-adjusted life 
years is a measure of differences of health in a population using a normative standard, and 
usually represents years of life lost (YLL) and years lived with disability (YLD) (GBD 2015 
DALYs and HALE Collaborators, 2016).  
 Individuals meeting the recommended iCVH criteria have demonstrated increased 
CVD-free survival and longer lifespan. Several prospective studies have indicated that 
healthy behaviors such as physical activity, not smoking and healthy eating reduce the 
incidence of CVD or myocardial infarction (Akesson, Weismayer, Newby, & Wolk, 2007; 
Chiuve, McCullough, Sacks, & Rimm, 2006; Li et al., 2018). In addition, healthy behaviors 
can significantly reduce mortality as reported in the 2016 Nurses’ Health Study, where the 
risk of total CVD and cancer mortality was reduced by up to 61% all-cause mortality, 60% 
cancer and 63% CVD mortality (Veronese et al., 2016).  A 2018  report from the Nurses’ 
Health Study supports these findings that maintaining five healthy factors contributed to 
more than 10 years of life expectancy (Li et al., 2018). Familial studies also show that 
offspring whose parents had CVD have a higher propensity to develop CHD and other 
cardiovascular diseases,  likely due to interactions of genetic predisposition, shared 
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environmental and behavioral factors (Bao et al., 1997; Nasir et al., 2004). Additionally, an 
inverse relationship between socioeconomic status (measured using an individual’s age, 
attained level of education, and income level) and CVD occurrence has been well-established 
and also contributes to  familial aggregation of CVD risk (P. A. Braveman, Cubbin, Egerter, 
Williams, & Pamuk, 2010; Min et al., 2017). This suggests that the overall burden of CVD 
may be increased in offspring whose parents had CVD, though little is known about parent-
offspring similarity of iCVH metrics and dose-response associations between iCVH metrics 
and CVD burden among parents and children.  
 To our knowledge, there is no published study designed to examine the familial 
aggregation of the combined effect of all seven iCVH metrics and CVD DALYs in parent-
offspring dyads. Accumulating evidence has demonstrated an inverse association between 
achieving an iCVH and future development of CVD and CVD mortality (Lachman et al., 
2016; Ogunmoroti et al., 2017; Shah et al., 2015; Xanthakis et al., 2014); although 
researchers have not explicitly investigated the mechanism through which the iCVH metrics 
specifically reduce CVD DALYs. In addition, there is no empirical evidence quantifying the 
CVD burden in terms of DALYs averted at different iCVH metrics leaving clinicians and 
health policymakers under-informed about the impact of the iCVH metrics on individual, 
family or population health (Willcox et al., 2006). The Framingham Heart Study (FHS) 
provides such a distinct setting to study iCVH metrics in a multigenerational prospective 
cohort of both parents and their offspring recruited from community dwelling participants.  
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Aims of the Study  
 The main aim of this study was to determine patterns and relationship of parental 
iCVH and offspring’s cardiovascular health and CVD disability adjusted life years. The 
specific aims and hypotheses are:  
 Specific Aim 1:  To examine the association of iCVH between parents and their 
offspring assessed at similar mean age over a determined life course. 
 Hypothesis 1A. Ideal cardiovascular health for parents will be positively correlated 
with that of their offspring at similar mean age.  
 Hypothesis 1B. Accounting for age, sex, socioeconomic status, and education level, 
the parents’ iCVH will be positively associated with that of their offspring at a similar mean 
age. 
 Specific Aim 2: To compare iCVH and the burden of CVD (CVD DALYs) between 
parents and offspring at exam cycles where the mean age at specific exam cycles are 
generally comparable. 
 Hypothesis 2A. Accounting for age, sex, education and income, the parents’ and 
offspring’s iCVH will be positively associated with CVD DALYs respectively. 
 Hypothesis 2B. Offspring of parents with low iCVH will have higher mean CVD 
DALYs compared to the mean CVD DALYs for offspring of parents with high iCVH. 
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Significance of the Study 
 Results of this study have potential to guide and inform patient and community 
based-programs that advocate for iCVH metrics in prevention of CVD and can also be used 
to counsel individuals on the positive impact of engaging in healthy behaviors. The study 
will potentially provide health policy makers with the needed actionable information that is 
key in life course epidemiology as well as inform the discussion on optimal allocation of 
resources to family-based primordial CVD prevention programs. 
Conceptual Framework  
 The conceptual framework for this study combines and integrates Family Systems 
Theory (FST) as conceptualized by Vendanthan et al. (2016) and Orem's self-care framework 
(OSCF). The complex interaction between parents and their offspring is approached from lens 
of FST. Family System’s Theory posits that a family exists within interconnected interactive 
social systems or subsystems which include parent-offspring interactions, caregiver-children 
and sibling interactions and that families have their own rules that guide their relationships 
(Fingerman & Bermann, 2000; Reiss, 1981). The theory’s argument that families’ rules, values 
and practices are shaped over time (Fingerman & Bermann, 2000) is an important addition to 
this study since an individual iCVH metrics and CVD outcomes are expected to be transmitted 
over the life course. Vendanthan and colleagues argued that family exists as a system with 
mutual interdependence and shared environment which interacts with parenting style or 
caregiver perceptions and genomics in lifespan promotion of cardiovascular health (see 
Figure 1.1 below) (Vedanthan et al., 2016). For this study, the concept of shared environment 
in FST was integrated with other OSCF concepts of self-care. Shared environment is critical 
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for family studies since parents and children live and interact at homes and neighborhood 
environments that promote or hinder access to safe places to exercise, purchase affordable 
healthy foods, be exposed to high density of fast food restaurants and stores that sell tobacco. 
Figure 1. 1 Family-Based Factors and Cardiovascular Health Promotion. A conceptual model 
showing relationship between family-based factors and cardiovascular health promotion. 
Adapted from “Family-based approaches to cardiovascular health promotion,” by R. 
Vedanthan, S. Bansilal, A. V. Soto, J. C. Kovacic, J. Latina, R. Jaslow… V. Fuster, 2016, 
Journal of the American College of Cardiology, 67(14), 1725–1737. 
https://doi.org/10.1016/j.jacc.2016.01.036 
 
 Dorothea Orem developed the self-care framework in the 1950s and the framework 
underwent further developments in the 1980s. The framework focuses on individuals deliberate 
actions to meet their own health goals or having power to meet their own health needs (Fawcett 
& DeSanto-Madeya, 2013; Orem, 1997). Orem’s view of human beings as “multiperson unit” 
will be used in this study as it focuses on situations where more than one person is interacting 
for their self-care (Geden & Taylor, 1999; Taylor, 2001). Multiperson units are relevant for 
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situations where the wellbeing of one person is subject to the effects of interactions among other 
persons (Fawcett & DeSanto-Madeya, 2013).  In this study, the well-being of the offspring is 
hypothesized to be influenced by that of the parents through complex interactions. 
 Orem’ Self-Care Framework  had  historical transformations to address the dynamic 
challenges of health care (Rizzo, 1987). Multi-person units such as family and resident groups 
were included to provide nursing care to different populations (Rizzo, 1987). Population was 
defined as individual members in a whole number of people in a community or a geographic 
area and that the individuals’ behavior is influenced by others within a population (Parker, 
2006; Rizzo, 1987). The multiperson unit, as opposed to self-care which mainly focuses on 
an individual unit, was adopted for the framework for this proposed study as it focuses on an 
aggregate, rather than an individual, therefore is appropriate for studies of population health. 
Multiperson unit can also be viewed as a dyadic unit where two or more persons, such as 
parents and children, have a mutual shared relationship as operationalized in this study 
(Geden & Taylor, 1999).  
 Family System’s Theory complements OSCF by explaining the possible relations that 
occur in families resulting in improvement or decline of cardiovascular health. The shared 
family environment concept is ideal for this study because parents and children interact both in 
physical environment (such as physical activity and food accessibility) and behavioral 
environment (practices such as smoking, feeding behaviors) in a complex family system 
(Vedanthan et al., 2016).  
 Parent-offspring relationship fits both FST and OSCF because children’s health 
behaviors are interlinked with those of the parents. Parents are the primary role models for 
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their young children, and the shared family environment for parents and their children forms 
a basis for lifelong learning and may influence strong role-modeling behaviors among the 
children (Faith et al., 2012). Orem’s theory views family as basic conditioning factor that 
influences self-care activities or enhances behavior change(Taylor, 2001). In this regard 
therefore, family acts as a resource for individuals to achieve self-care requisites and setting 
where children rely on their parents to model some health-associated behaviors beginning in 
the early stages of development. 
 Conceptual-theoretical-empirical (CTE) structure. In the CTE structure (Figure 
1.2), shared family environment is proposed to interact with multiperson unit, therapeutic 
care demand and basic conditioning factors to influence individuals’ cardiovascular health 
and burden of CVD. The physical and behavioral aspects of shared family environment align 
well with therapeutic care demand and basic conditioning factors from the OSCF. 
Multiperson unit is viewed as interaction between parents and their offspring, resulting in 
modification of health behaviors. Therapeutic self-care demand concept entails all required 
regulatory care for parents and offspring to maintain cardiovascular health. Therapeutic self-care 
demand is viewed as activities which the participants can perform to remain healthy, in this 
case, the iCVH metrics that are necessary for maintaining cardiovascular health.  
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Figure 1. 2 Conceptual-theoretical-empirical structure for iCVH self-care.  Key: C, 
conceptual; T, middle range theory; E, empirical research methods; BMI, body mass index; 
BP, blood pressure, TC, total cholesterol; FBS, fasting plasma glucose; FHS, Framingham 
Heart Study; DALYs-disability-adjusted life years 
 
  Basic conditioning factors relate to population characteristics that affect their care, 
including age, sex, sociocultural, and resource availability (Fawcett & DeSanto-Madeya, 
2013).  These therapeutic self-care demand and basic conditioning characteristics are nurtured 
in a shared family environment where initial self-care is learned. The process by which 
acquisition of behaviors among members of families occurs is not explicit.  However, valuing of 
specific health behaviors may be modelled early in life in family settings because of strong 
social bonds and need to promote wellbeing of all members of the families (Taylor, 2001). Self-
care deficit occurs when the individuals are not able to meet the requisite care demand such as 
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recommended iCVH metrics (Fawcett & DeSanto-Madeya, 2013). Deterioration of self-care 
deficit would lead to chronic conditions such as cardiovascular disease or even death from 
persistent ill-health. Chapter 2 presents a review of the literature on the state-of-science 
regarding iCVH and familial aggregation of CVD and highlight gaps in knowledge. Chapter 3 
presents methods for closing some of the identified gaps using an established longitudinal multi-
generational public use dataset. 
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CHAPTER 2 
LITERATURE REVIEW 
Background 
Cardiovascular disease (CVD) continues to be the leading cause of death globally 
accounting for 31% (17.7 million people) of all global deaths annually (World Health 
Organization [WHO], 2017b). The burden of CVD is greater in the low- and middle-
income countries (LMICs) which experience more than 75% of the global CVD deaths. In 
the United States, coronary heart disease (CHD) is the most common CVD and the 
leading cause of mortality (45%) followed by stroke, heart failure, high blood pressure, 
arterial diseases (16.5%, 8.5%, 9.1%, 3.2%, respectively). The WHO defines CVD as a 
constellation of heart and blood vessel disorders which include CHD, cerebrovascular 
disease (stroke), peripheral arterial disease, rheumatic heart disease, congenital heart 
disease and deep vein thrombosis and pulmonary embolism (WHO, 2017b). However, for 
this study, CVD is operationally defined in the methods section using the FHS criteria.  
The prevalence of CVD among American adults is approximately 28%, but 
disproportionately affects the non-Hispanic blacks whereby nearly half (~50%) have some 
form of CVD (AHA, 2018b). Evidence from multiple studies consistently report racial 
disparities in CVD risk factors. For instance, the highest prevalence of elevated blood 
pressure was observed among non-Hispanic blacks; diabetes, smoking and abdominal 
obesity was highest among Hispanic individuals (Gasevic, Ross, & Lear, 2015). A study 
of iCVH among US adults in 2011 and 2012 also revealed disparities in iCVH metrics 
where non-Hispanic black women (iCVH difference=0.93, P=0.001) and Mexican-
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American women (iCVH difference=0.71, P=0.02) had lower iCVH scores compared 
with non-Hispanic white women (Pool, Ning, Lloyd‐Jones, & Allen, 2017). These 
differences are mainly attributed to social determinants of health such as access or lack of 
access to resources including neighborhoods with fewer grocery stores , recreation, and 
exercise facilities, all of which are associated with  iCVH (Unger et al., 2014). Regarding 
socioeconomic status, studies have shown that there is an inverse relationship between 
socioeconomic status and CVD.  Research from the Jackson Heart Study revealed that 
low income was a strong correlate of myocardial infarction (OR 3.53, 3.53; 95% CI, 2.31–
5.40) and stroke (OR: 3.73; 95% CI, 2.32–5.97) (Min et al., 2017). In addition, attainment 
of higher education and higher income is linked with more favorable health outcomes and 
improved lifestyle behaviors which are associated with reduced CVD risk (P. A. 
Braveman et al., 2010; P. A. Braveman, Egerter, & Mockenhaupt, 2011; P. Braveman, 
Egerter, & Williams, 2011). 
Disparities of CVD DALYs in the United States are also evident. A recent study 
investigating the burden of CVD in the United States between 1990 and 2016 showed that 
CVD DALYs were twice as prevalent in men compared with women and largely 
attributed to ischemic heart disease (Global Burden of Cardiovascular Diseases 
Collaboration et al., 2018). Of all the states, Mississippi had the highest age- standardized 
CVD DALYs (4982 DALYs per 100 000 persons) and the lowest was Minnesota (2352 
age-standardized DALYs per 100000 persons). Unhealthy diet, high systolic blood 
pressure, BMI, total cholesterol, fasting plasma glucose, tobacco smoking and physical 
inactivity were the leading risk factors for high CVD DALYs. As expected, the CVD 
 14 
 
DALYs increased after age 40 years and reached peak by age 65 (Global Burden of 
Cardiovascular Diseases Collaboration et al., 2018).  
Approached from the lens of life-course epidemiology, cardiovascular disease risk 
factors such as smoking cigarettes and physical inactivity are potentially modifiable. Even 
in individuals who are genetically predisposed to developing CVD, healthy lifestyle 
factors such as consumption of healthy diet throughout the lifespan has been  associated 
with lower risk of  developing CVD (Khera et al., 2016).  Consistent with this assertion, 
Life Simple 7 factors are recommended for maintaining iCVH; however, it remains 
elusive how to attain or maintain all the recommended iCVH levels over time. 
The exceedingly high economic burden due to CVD contributes to loss of optimal 
health and substantial human suffering for affected populations. To address this crisis, the 
WHO has recommended cost-effective interventions, popularly known as “best buys” 
interventions, to be implemented in all settings including the under-resourced countries. 
These interventions implemented at the national population level include smoking control 
policies, availing public spaces for physical activity, raising taxation for salt, fat and 
sugar-rich foods and providing healthy diets for school children (WHO, 2017a). Similarly, 
the AHA recommends attainment of the iCVH metrics with main messages emphasizing 
maintenance of  smoke -free lifestyles, healthy patterns  of physical  activity and dietary 
intake and maintenance of a healthy weight blood pressure, cholesterol and blood glucose 
at specified levels (AHA, 2013). The WHO’s global action plan targets prevention and 
control of non-communicable diseases (NCDs) by the year 2020, specifically to reduce by 
25% premature deaths from CVD and other NCDs (WHO, 2017a). This target  
approximates the AHA’s 2020 Impact Goals which targets a 20% improvement of 
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cardiovascular health and reduction of CVD and stroke mortality by 20% by the year 
2020 (AHA, 2013).  
The United Nations (UN) also advocates for achieving an optimal health across 
the life span (United Nations, 2016). This is documented in the UN Sustainable 
Development Goal (SDG) 3 which targets achievement of health and well-being and 25% 
reduction of premature mortality from NCDs by 2030. A significant portion (75%) of 
premature mortality due to NCDs globally is attributed to CVD and cancer; hence, this is 
also an important SDG issue (United Nations, 2016). The Global Burden of Disease 
(GBD) study 2016 has embarked on tracking health-related SDGs to advise governments 
on the health situation of their populations (GBD 2016 SDG Collaborators, 2017). The 
efforts to track iCVH metrics on a global level is a novel way for assessing the attainment 
of health-related SDGs across different countries and impacts on policies that address 
health problems faced in those countries. Health-related SDGs may be quantitatively 
measured differently from iCVH, but one salient finding is that both iCVH and most of 
SDGs are associated with sociodemographic factors (GBD 2016 SDG Collaborators, 
2017). 
History and Definition of Ideal Cardiovascular Health (iCVH) 
 The AHA Strategic Planning Task Force commissioned the concept of iCVH in June 
2007 with the aim of developing and implementing the 2020 Impact Goal (Lloyd-Jones et al., 
2010). The focus of AHA Impact Goal for 2010 targeted reducing CHD and stroke risk 
factors and mortality rates. The AHA committee defined iCVH using the Life Simple 7 
factors (as defined earlier in chapter 1) for prevention of CVD, and that definition was 
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adopted in 2010 by AHA  (Lloyd-Jones et al., 2010).  The AHA approved the 
recommendation to improve the cardiovascular health for Americans by 20% and reduce by 
20% the incidence of CVD and stroke deaths by the year 2020. To meet the AHA criteria for 
iCVH, an individual must attain all the seven components at ideal levels. These ideal 
components are highlighted in Table 3.3 in the methods section. 
Ideal Cardiovascular Health and Relation to the AHA’s Strategic Impact Goal Through 
2020 and Beyond 
  Using data from the cross-sectional National Health and Nutrition Examination 
Surveys (NHANES), the AHA tracks the iCVH metrics and targets to report the attainment 
of iCVH by the year 2020. These goals can be evaluated and monitored using studies focused 
on iCVH metrics and CVD incidence and mortality. Large prospective cohort studies have 
shown comparable trends that participants with iCVH experience significantly reduced 
incidence of heart failure, even among different racial-ethnic groups (Lachman et al., 2016; 
Ogunmoroti et al., 2017; Shah et al., 2015; Xanthakis et al., 2014). The Honolulu Heart 
Program/Honolulu Asia Aging Study demonstrated that most of ideal health factors were 
associated with longevity and reduction in disability, but questions still exist on the specific 
implications of the health factors in shaping and informing health care policy (Willcox et al., 
2006). Other studies focusing on one or more health behaviors such as not smoking 
cigarettes, having normal BMI, engaging in physical activity for at least 30 minutes daily, 
drinking not more than 2 glasses of wine per day, a low glycemic diet with low fat content, 
serve to cumulatively reduce the incidence of CHD or myocardial infarction by up to 92% 
(Akesson et al., 2007; Chiuve et al., 2006; Kyu et al., 2016; Reid et al., 2014). 
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  The association of lifestyle factors on life-expectancy and incident CVD has been 
widely investigated.  Examples include studies conducted by Veronese and colleagues 
(2016), the Health Professionals Follow-up Study (HPFS) (n=74, 582 men) and the Nurses’ 
Health Study (NHS) (n=39, 284 women). These prospective cohort studies focused on the 
association of diet, physical activity, alcohol use, smoking and BMI and CVD mortality. Risk 
reducing factors were defined as avoidance of cigarette smoking, engaging in moderate- to -
vigorous physical activity (MVPA) for ≥30 min/day, limiting alcohol consumption to 5-15 
g/day for women, or limiting to 5-30 g/day for men, and an alternate healthy eating index 
(AHEI) diet score in the upper 40%. The AHEI diet score is derived from the recommended 
servings of fruits, vegetables, whole grains, nuts and unsaturated fats, processed meats, 
sugars and sodium and multivitamins (Veronese et al., 2016). Findings from a 32-year 
follow-up study accounting for the three protective lifestyle factors stated above and low 
BMI (18.5-22.4 kg/m2) indicated that the hazard for CVD mortality was significantly reduced 
(hazard ratio [HR] 0.37, 95% CI: 0.29-0.46) (Veronese et al., 2016). Another most recent 34-
year longitudinal Nurses’ Health Study found that five-low risk health factors defined as no 
smoking, normal BMI (18.5-24.9 kg/m2) physical activity (moderate- to- vigorous 
≥30minutes/day) moderate alcohol intake and healthy diet (upper 40% diet score) resulted in 
reduced all-cause mortality (HR 0.26, 95% CI, 0.22-0.31) and CVD mortality (HR 0.18, 95% 
CI 0.12-0.26), and lead to an average increase of 14 more years of life (Li et al., 2018). This 
points to the impact of combined CVD risk factors in prevention or reduction of CVD 
burden. 
 Further examination of healthy behavioral-lifestyle factors demonstrates a strong 
protective association with incident CVD. In a 16-year prospective US study of 42, 487 male 
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health professionals aged 45-75 years, five healthy indicators (smoking abstinence, limiting 
alcohol consumption, healthy diet, physical activity as defined above and BMI <25 kg/m2) 
were associated significantly with an 87% reduced risk of CHD (Chiuve et al., 2006). The 
risk of CHD was not altered by antihypertensive or cholesterol drugs pointing to the 
importance of lifestyle in prevention of CHD. Similar associations were observed among 
older populations in other parts of the world. In Europe for instance, an 11-country 
longitudinal study involving 2, 339 individuals aged 70-90 years of age observed that the 10-
year survival rate from all causes was higher for those with four healthy factors (related to  
physical activity, smoking, limited alcohol consumption, and diet) compared with  
individuals who reported 0-1 healthy behaviors (75% and 50% respectively) (Knoops et al., 
2004).  
 Behavioral-lifestyle health factors are also associated with disability. Growing 
evidence from prospective cohort studies suggests that participants with favorable health 
factors manifest with reduced disability as age increases.  In  a Taiwan longitudinal study of 
1940 men and 1247 women aged 60 years and older, the combined effect of health factors on 
functional disability attributed to one or more healthy behaviors contributed 15% to 75% 
reduction in functional disability (Liao et al., 2011). Functional disability was defined as the 
inability to perform activities of daily living (ADL) comprised of unassisted bathing and 
ability to walk for 200-300 meters. Healthy behaviors were defined as not smoking, none or 
moderate alcohol consumption, regular exercise and maintaining 6 to 8 hours per day of 
sleep (Liao et al., 2011). In another cohort study (1986–2005) of 2327 college alumni, 
lifestyle risk factors were found to predict disability and mortality among healthy aging 
adults with mean baseline age of 68 (SD 3.6) years (Chakravarty et al., 2012). Three risk 
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groups were created based on the number of baseline characteristics as no risk factors (low-
risk), one risk factor (medium), two or more risk factors (high-risk); the risk factors measured 
were BMI, cigarette smoking, and physical inactivity. Individuals 65 years of age and older 
at no risk at baseline experienced 8.3 years delayed onset of moderate disability compared to 
those at high-risk. Mortality rates were 384 per 10, 000 person- years compared with 247 per 
10, 000 person-years for high-risk and low-risk groups respectively (Chakravarty et al., 
2012).  
 Similarly, in another longitudinal study, the onset of disability was delayed by five or 
more years among middle-aged participants with favorable health behaviors (Vita, Terry, 
Hubert, & Fries, 1998). No gender differences were observed in the trends for time to 
disability onset. Vita et al. (1998) investigated the relationship between health behaviors 
(smoking, BMI, and exercise) at a mean age of 43 years and cumulative disability later in life 
from 66 to 74 years (n=1741). Risk scores were calculated using smoking, BMI and exercise 
variables where subjects were assigned risk level depending on the total score (0 to 2: low-
risk; 3 to 4: moderate risk; 5 to 9: high-risk). Among those with favorable health behaviors 
compared with those with least favorable health behaviors, the disability index was 0.49 
versus 1.02 respectively (Vita et al., 1998).  In addition, disability index was similar among 
the offspring where individuals with the least favorable health behaviors had double the 
disability index compared to those with favorable health behaviors  (Vita et al., 1998). 
 Combination of iCVH metrics at the recommended levels could synergize overall 
cardiovascular health achievement throughout the lifespan as demonstrated in the 
Atherosclerosis Risk in Communities (ARIC) study where four combined factors defined as 
untreated cholesterol (<200mg/dl), blood pressure (<120/80 mmHg), no diabetes and never 
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smoked were investigated (Hozawa, Folsom, Sharrett, & Chambless, 2007). Results of this 
study showed that individuals with optimum combined health factors were 88% less likely to 
die due to CVD (HR 0.12, 95% CI 0.04-0.31) compared with those with any elevated risk 
factors; while borderline attainment of combined health factors reduced CVD mortality risk 
by 72% (HR 0.28, 95% CI 0.21-0.37). Also, combined optimum risk factors reduced all-
cause mortality by up to 74% (HR 0.26, 95% CI 0.17-0.38) among all races. Population 
attributable fraction (PAF) results indicated that having at least 1 elevated and borderline risk 
factors accounted for 84.7% CVD mortality among all races, 100% among African American 
men and women, 88.6% in White women and 72.1% in White men (Hozawa et al., 2007).  
 Several implications for having iCVH exist, such as increased longevity and 
morbidity-free survival, improved health-related quality of life even in old age and lower 
treatment costs in old age (Chakravarty et al., 2012; Hozawa et al., 2007).  Taken together, 
these results indicate that such benefits are not currently fully realized by the American 
population since only extremely small proportion of Americans (5%) [other studies show 
even lower prevalence of <2% (AHA, 2017a)] attain all seven iCVH metrics (Chiuve et al., 
2006; Ford, Li, Zhao, Pearson, & Capewell, 2009; Lloyd-Jones et al., 2006).  In addition, 
collective results indicate the need for urgent measures to address the main factors that lead 
to poor iCVH metrics and the roles of lifestyle activities in addition to genetic predisposition 
to CVD. 
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Prevalence of Cardiovascular Disease Risk Factors (Life’s Simple 7) in the United 
States 
Smoking. The prevalence of smoking among persons aged 18 years and older in 
the United States is 15% (males 16.7% versus 13.7% females) (CDC, 2016). In 2015, 
Non-Hispanic American Indians or Native males had the highest smoking rates of 22%, 
while Hispanics and Asians were least likely to smoke at 10% and 7% respectively 
(American Heart Association, 2018b). In 2015, about 1 in 5 deaths (480, 000) among 
Americans was attributed to cigarette smoking. These estimates were taken from 
individuals who reported smoking more than 100 cigarettes at any point in their life and 
currently smoking either daily or some days (CDC, 2016). 
Physical activity. The AHA recommends moderate activity of at least 30 minutes 
per day for five days per week  or 150 minutes a week or 75 minutes of vigorous activity 
per week (AHA, 2017b, 2018b). About 30.4% of the US population is physically inactive 
(American Heart Association, 2018b). In 2015, only 21.5% of American adults and 27.1% 
of American adolescents achieved recommended leisure-time aerobic and muscle-
strengthening levels of physical activity (Benjamin et al., 2018).   
Healthy Diet. The prevalence of healthy diet between 2003 and 2012 among 
children and adults using the ideal health score increased from 0.2% to 0.6% and 0.7% 
and 1.5%, respectively (American Heart Association, 2018b). This marginal improvement 
in healthy diet from 2003 to 2012 could be attributed to an increase in whole grain 
consumption and reduced consumption of sugary drinks; however, substantial 
improvement is warranted since achievement of a healthy diet in both adults and children 
remains quite low. In general, the AHA recommends (for adults) a healthy diet comprised 
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of vegetables and fruits (4-5 servings/day), whole grains rich in fibers (6-8 servings/day), 
nuts and legumes (4-5 servings/week), poultry, meat and eggs (8-9 servings/week) and 
fish (less than 6 oz/day), skimmed or low fat (1%) milk and unsaturated fats (2-3 servings 
per day or 27g/day for oils or 20g/day for saturated fats for a 2,000-calorie level (U.S. 
Department of Health and Human Services and U.S. Department of Agriculture, 2015). In 
addition, the diet should be low in sodium (not more than 2400mg per day) and low added 
sugar (5 or fewer servings/week, for instance, 1 serving of sugar= 1 Tbsp sugar; 1 serving 
of lemonade=1 cup lemonade) (AHA, 2018b; Eckel et al., 2013). Similarly, WHO 
recommends a healthy diet that is rich in fruits, vegetables, legumes, unprocessed nuts and 
whole grains. At least five servings of fruits and vegetables are required per day, not more 
than 10% and 30% of total energy intake from sugars and fats respectively and salt intake 
of less than 5 grams per day (WHO, 2015).  
Body mass index. The prevalence of obesity among adults in the United States 
increased from 30.5 % in 1999 to 2000 to 37.7% in 2013 to 2014 (AHA, 2018b). The 
prevalence of obesity and overweight among adults in the United States is on the increase 
from 65.1% in 1999-2002 to 70.9 in 2013-2016 (Centers for Disease Prevention and 
Control, 2017a). Among adult Americans aged 20 years and above, racial and ethnic 
differences exist where Mexican Americans had the highest prevalence of obesity and 
overweight (83.8%) in 2013-2016 compared with Hispanic American (80.4%), African 
American (76.1%) and Whites (75.3%) and lowest in Asian Americans (42.7%) (Centers 
for Disease Prevention and Control, 2017a). Among children and adolescents, the 
prevalence of obesity was 9.4%, 17.4% and 20.6% among children aged 2-5 years, 6-11 
years and adolescents aged 12-19 years, respectively in 2014 (AHA, 2018b), which points 
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to increased future risk of CVD if this trend continues and prevention of overweight is not 
addressed early in life.  
Cholesterol. The prevalence of total blood cholesterol greater than 200mg/dL 
among US adults is 39.7% and  highest in non-Hispanic White females (43.4%) and 
lowest in non-Hispanic black males (32.6%) and children 7% (AHA, 2018b; CDC, 2017). 
In 2012, about 37% of American adults had high levels of low-density lipoprotein (a well-
established  risk  factor for heart disease and stroke) while 18.7% had the appropriate, 
gender and age-specific levels of cardioprotective high-density lipoprotein (AHA, 2018b; 
CDC, 2017).  Between 2011-2014, the prevalence of high total cholesterol (≥200 mg/dL) 
among US children and adolescents aged 6–19 was 7.4%; girls had higher prevalence 
(8.9%) compared to boys (5.9%); non-Hispanic Asians had the highest prevalence 
(10.9%) while Hispanics had the lowest (6.3%) (Centers for Disease Prevention and 
Control, 2015a). 
Blood pressure. The most recent 2017 American College of Cardiology 
(ACC)/AHA guidelines define hypertension as blood pressure of 130/80 mm Hg and 
above, a 10 mm Hg lower than previous classification of 140/90 mm Hg and above 
(AHA, 2017a). This lower value increases the proportion of individuals who meet the 
criteria for hypertension and has implications for practice regarding new treatment 
guidelines and lifestyle changes. Approximately 46% of American adults have high blood 
pressure using the most recent 2017 ACC/AHA guidelines and about 78, 862 deaths were 
attributed to high blood pressure in 2015, a rise by 37.5% from 2005 (AHA, 2018b). 
Similarly, new blood pressure guidelines for pediatrics were developed to align with adult 
guidelines, where the term “prehypertension” was replaced with “elevated blood pressure” 
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(Flynn et al., 2017). Currently pediatric blood pressure is classified in three categories by 
age and sex: (1) elevated blood pressure ≥90th percentile, (2) stage 1 hypertension ≥95th 
percentile, and (3) stage 2 hypertension ≥95th percentile+12 mm Hg. These guidelines 
estimate the US prevalence of pediatric hypertension at 2-5%; however, estimates suggest 
that 75% of the hypertension cases in children are undiagnosed (Flynn et al., 2017). 
Diabetes. The 2015 prevalence of type 2 diabetes among American adults was 
9.1%, with non-Hispanic black males having the highest prevalence and among non-
Hispanic white females the lowest (14.1%; 7.4% respectively) (AHA, 2018b). These 
precise estimates of the US burden of diabetes are further confounded by the high 
proportion of individuals with undiagnosed diabetes (7.6 million adults) and an additional 
81.6 million prediabetic adults (33.9%) (AHA, 2018b).  Between 2002 and 2012, the  
incidence of type 2 diabetes among youth aged 10-19 years increased by 7.1% annually 
(9.0 cases/100, 000 youths in 2002 to 12.5 cases/100, 000 youths in 2012) (Mayer-Davis 
et al., 2017). By race, adjusted annual incidence of type 2 diabetes increased by 8.9% for 
Native Americans, 8.5% for Asian/Pacific Islander, 6.3% for non-Hispanic blacks, 3.1% 
for Hispanics and 0.6% for non-Hispanic whites (Mayer-Davis et al., 2017). 
Familial Aggregation of Cardiovascular Disease and Ideal Cardiovascular Health 
Metrics 
 There is evidence of familial clustering of adverse  health behaviors,  that also 
contributes to  familial aggregation of CVD (Imes & Lewis, 2014). The majority of studies of 
familial aggregation suggest the existence of  positive parent-offspring correlations of single 
CVD risk factors such as elevated BMI, physical inactivity and poor diet (Fuemmeler, 
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Anderson, & Mâsse, 2011; Johnson et al., 2012; Massarani et al., 2015). In addition, there is 
substantial evidence that atherosclerotic and hypertensive processes  begin early in life and 
are influenced  over time by  modifiable risk factors (Hayman & Worel, 2015; Juonala et al., 
2010; Loria et al., 2007). In addition, favorable iCVH metrics in childhood are cumulatively 
associated with lower incidence of hypertension, metabolic syndrome, low-density 
lipoprotein, and carotid artery intima-media thickness in adulthood (Laitinen et al., 2012; 
Pulkki-Råback et al., 2015). These findings suggest that iCVH in childhood can help reduce 
future burden of CVD later in the life course.  
 Familial transmission of cardiovascular health benefits from parents to children 
through behavioral-lifestyle factors holds promise and potential for intergenerational 
prevention of CVD morbidity and mortality. The precise pathway for intergenerational 
influence of health behaviors is complex. However,  studies suggest that socioeconomic 
factors such as education and household income contribute positively to that pathway 
(Martin, Van Hook, & Quiros, 2015) as demonstrated by cumulative evidence from multiple 
studies linking educational attainment and higher income to favorable health outcomes 
throughout the life course (P. A. Braveman et al., 2010; P. A. Braveman, Egerter, & 
Mockenhaupt, 2011; P. Braveman, Egerter, & Williams, 2011). Parental educational 
attainment has also been linked to increased knowledge, increased health literacy and 
improved health behaviors as these individuals tend to make more informed health-related 
choices for themselves and their families (P. Braveman et al., 2011; Sanders, Federico, Klass, 
Abrams, & Dreyer, 2009). In a study of 1480 parent-offspring  dyads, higher parental 
educational attainment was associated with healthier clusters, and positively related to 
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improved physical activity and healthy diet (Rodenburg, Oenema, Kremers, & van de 
Mheen, 2013). Similarly, educational attainment is a major contributor to employment 
opportunities, whereas individuals with lower educational attainment face higher rates of 
unemployment, which, in turn, is a risk factor for more adverse CVD outcomes (Walter, 
Glymour, & Avendano, 2014). 
 Research on iCVH metrics is important in family-based studies since parents serve as 
powerful role models for observed behaviors which would consequently impact their 
children’s health behaviors. For instance, a family healthy feeding cluster-randomized trial in 
London, United Kingdom, showed positive parent-offspring correlations, with significant 
associations in fruit or vegetable intake (r = 0.52, P < 0.001) and healthy drinks or water (r = 
0.54, P < 0.001) (McGowan et al., 2013). Children’s intake of fruits, consumption of 
saturated fats, and physical activity and other health behaviors were correlated with the 
parents’ or caregivers’ practices (Isgor, Powell, & Wang, 2013; Martin et al., 2015). 
However, the effect of familial aggregation of combined iCVH metrics has not been 
empirically quantified. Most studies on familial aggregation of health factors investigated 
only a single or few iCVH metrics with limited attention paid to the intergenerational 
transmission of iCVH from parents to children and the corresponding future burden of CVD 
in offspring that is attributed to iCVH metrics.  
Shared Common Family Environment and Ideal Cardiovascular Health 
 Offspring living with their parents in childhood years share common parental 
socioeconomic status, practices or values, living conditions such as housing or neighborhood 
(Kjøllesdal, Ariansen, Mortensen, & Næss, 2017). However, it is assumed that parents and 
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children shared early life environment not withstanding if some parents separated early in 
children’s life (or moved to another location out of Framingham area, which is beyond the scope 
of this study). Since the causes of most familial diseases are complex, and influenced by  an 
interaction of genetic and environmental factors, most family-based studies have attempted to 
account for the hereditability of diseases from the genetics view point; however, these studies 
can only explain a fraction of family factors associated with disease (Muñoz et al., 2016). The 
UK Biobank study  investigating the role of genetics and familial shared environment showed 
that the “missing hereditability” of the common chronic diseases such as CVD is attributable to 
family lifestyle or environmental effect, which most studies do not take into account (Muñoz et 
al., 2016).  
 It is well established that offspring of parents with CVD are more likely to develop CVD 
in adulthood (Bao et al., 1997), which is mainly linked to genetic interplay between parents and 
children. However, other studies report that parent-offspring concordance in phenotypic 
expression of selected CVDs and associations with other CVD risk factors such as obesity are 
also moderated substantially by family environmental factors such as exercise, diet, smoking 
(Nielsen, Nielsen, & Holm, 2015). The attributable risk of genetic factors to potentially 
modifiable health factors has been examined extensively.  For instance, the contribution of 
hereditability to waist circumference ranges from 39-79%, fasting glucose 7-77%, diastolic 
blood pressure 20-66%, total cholesterol 8-72% (Elder et al., 2009). However, most of these 
studies included monozygotic or dizygotic twins, not representative of the general population 
and may overestimate hereditability or variance of the inherited factors due to their limited 
genetic heterogeneity. In addition, most of the studies did not account for shared familial 
lifestyle or environmental and behavioral factors such as smoking, exercise, diet, neighborhood 
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type, among others, which are known to substantially influence such phenotypic expression of 
inherited CVD risk factors (Elder et al., 2009; Sun et al., 2013). Taken together, accumulated 
evidence from twin-family studies and  population based epidemiological studies  suggest that 
parents’ health behaviors , patterns of dietary intake, smoking and physical activity as well as 
socioeconomic factors influence intergenerational  transmission of CVD risk factors,  and point 
to the important  role of the shared common family environment  in CVD manifestation across 
generations (Sun et al., 2013).  
Definition of Disability-Adjusted Life Years (DALYs) 
 The burden of a particular disease is usually calculated from disability-adjusted life 
years (DALYs) for that specific disease and can be directly estimated from specific health 
behaviors or interventions  (Lopez, Mathers, Ezzati, Jamison, & Murray, 2006). Disability-
adjusted life years are the sum of two quantities: (1) the number of years of healthy life lost 
(YLLs) due to premature death, and (2) the number of years lived with disability (YLDs) as 
demonstrated in Figure 2.1 below (WHO, 2017c). For example, assume the life-expectancy 
of Country X is 80 years. If an otherwise healthy individual die suddenly in an accident at 
age 60 years, their YLD is 0, and their YLL=20 (80-60 years); therefore, contribution to 
DALYs is 20 years. On the other hand, if the individual is diagnosed with CVD at age 55 and 
dies at 60 years, their YLD=5 (60-55), their YLL=80-60=20, therefore their DALYs= YLD + 
YLL=5+20=25. A region, country, or population with a low burden of a particular disease 
will have few DALYs associated with that disease. However, elevated DALYs are associated 
with a high burden of a disease or when life expectancy is short, or disease treatment and 
management is suboptimal.  
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Figure 2. 1. Diagram to show components of disability-adjusted life years. Adapted from 
https://www.slideshare.net/souravgoswami11/burden-of-disease-analysis  
 
 The DALYs concept was initiated in 1993 in the first Global Burden of Diseases 
(GBD) study (GBD 2015 DALYs and HALE Collaborators, 2016). Use of DALYs is simple 
but powerful in terms of estimating the progress and difficulties in achieving a certain health 
status and can be used to monitor disease burden and healthy life over time and therefore 
captures the health gap of the population against a standard ideal health status. The GBD 
study has been instrumental in providing advice to countries on priority areas in the 
allocation of healthcare resources. Without considering the magnitude of DALYs, it is quite 
difficult to deliver effective and timely high-quality health care interventions without 
understanding the key disease burdens and tracking population health status trends (Murray 
& Lopez, 2013). 
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Importance of Cardiovascular Disease DALYs  
 Epidemiologic studies have demonstrated the association between some iCVH 
metrics and incident CVD and CVD mortality, but most have not attempted to quantify the 
impact of all seven iCVH metrics in the reduction of CVD DALYs (Veronese et al., 2016). It 
has been shown that a health-gap exists between the recommended iCVH status and the 
prevailing health situation which needs to be addressed. World Health Organization has 
recommended use of GBD methods such as DALYs for national or sub-national level to 
study needs specific to each country (WHO, 2018b). One DALY represents the loss of the 
equivalent of one year of complete health. About 60% of global DALYs arise from 
premature mortality. In 2004, the global average burden of disease was 237 per 1,000 
population (World Health Organization, 2008). In 1990, global CVD DALYs loss was 85 
million and was predicted to nearly double to 150 million by 2020 (Vilahur, Badimon, 
Bugiardini, & Badimon, 2014). In  the United States, ischemic heart disease is the number 
one cause of death (21.1%), years of life lost (15.9%), years lived with disability 1.9%) and 
DALYs of 7, 850 (9.6%) per 10, 000 population (Murray & Lopez, 2013). 
 Due to the increased demand for health resources in the society, strategic planning is 
needed to attain certain health goals using the available limited resources. Policy makers 
would not be well informed to make rational decisions for health resources allocation if such 
comparative burden of disease is not known. The AHA strategic planning committee 
recommended monitoring of iCVH metrics from 2010-2020. The health-related quality of 
life (HRQOL) was recommended to be done as a secondary measure for AHA 2020 impact 
goals due to the availability of disease-specific HRQOL measures in the literature (Lloyd-
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Jones et al., 2010). However, it is known that use of HRQOL scales may not be adequate in 
most national databases and may also not be feasible to measure in all datasets (Karimi & 
Brazier, 2016). Health-related quality of life scales are also subjective as they involve 
individual’s perception of their quality of life and may not indicate comparable standards 
across different populations (Karimi & Brazier, 2016).Therefore, DALYs may serve as a 
valuable tool for measuring the impact of iCVH on CVD as it captures population’s health 
gap against an established normative standard (GBD 2015 DALYs and HALE Collaborators, 
2016); this is important to the policy makers to quantify how much iCVH contributes to the 
reduction of CVD burden.  
Benefits and Controversies of DALYs in Estimating Disease Burden 
 Although widely used in the measurement of global burden of disease literature 
(GBD 2015 DALYs and HALE Collaborators, 2016; GBD 2016 SDG Collaborators, 2017; 
Murray & Lopez, 2013; WHO, 2018b), critics fault the assumptions and value judgments,  
conceptual and technical basis for DALYs (Anand & Hanson, 1997). For example, disability 
weights for calculating societal preferences at different health states may not necessarily be 
in tandem with the lived experiences with or without disability since it simply implies 
societal preferences for such health states (Anand & Hanson, 1997). Another limitation is 
that a diagnosis of CVD does not necessarily impact quality of life the same way in all 
individuals. Note that disability weights denote severity of a disease on a continuum scale 
from 0 (perfect health) to 1 (death) (WHO, 2018b). 
 In addition, the 5% annual discount rate has been suggested to be reduced to 3% by 
the environmentalists and renewable energy stakeholders, therefore politicizing DALYs. The 
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concept of discounting presupposes that there is a social preference of a healthy year lived 
now than in the future (in other words, a year lived now is better than a year lived in the 
future), and this is achieved by decreasing the value of life years gained annually at that fixed 
percentage (World Health Organization, n.d.). The environmentalists and renewable energy  
advocates argue for this rate discounting in order to align with World Bank Disease Control 
Priorities Study and GBD, which uses 3%, as well as US Panel on Cost-Effectiveness in 
Health and Medicine which also support the use of 3% to discount for cost and health 
outcomes  (World Health Organization, n.d.). The WHO recommends a 3% annual 
discounting (World Health Organization, 2017c).  
Research Gaps and Innovation 
 Findings of most studies conducted to date are consistent with familial aggregation of 
some iCVH metrics, but no known study has investigated the relationships of all the seven 
iCVH metrics, especially among paired parent-offspring dyads. This is one gap this study 
attempted to address. Furthermore, there is lack of data on quantification of iCVH to reduce 
incident CVD or CVD disability-adjusted life years. Most studies have focused on the 
clinical occurrence of CVD or mortality using a single examination of few health factors at 
baseline. This has limitations in that iCVH tends to decline with age (Shah et al., 2015) and 
hence examining trend of iCVH metrics over time might yield more accurate estimations of 
CVD impact. This is another gap this study attempted to address. 
 Ideal cardiovascular health has received much attention since the term was coined in 
2010. To increase uptake of self-care programs by the policy makers and the patients, 
convincing evidence is needed on the extent to which health factors impact the health of 
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populations. As much as there is increasing evidence to show how atherosclerosis originates 
in childhood (Hayman & Worel, 2015; Juonala et al., 2010; Loria et al., 2007), there lacks 
specific data on familial aggregation of combined iCVH metrics and CVD outcomes (Loria 
et al., 2007). Because most behavioral factors such as dietary patterns and physical activity 
patterns are formed in childhood, and may worsen in adolescence (CDC, 2011), there is need 
for familial aggregation studies to inform parents and policy makers on how best to increase 
health behaviors in the general population by targeting family environments. Improving 
iCVH among the parents has potential to improve iCVH in children and eventually improve 
cardiovascular health, reduce the burden of CVD mortality (CDC, 2011). To address this 
gap, the burden of CVD attributed to iCVH metrics for parents and children was estimated. 
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CHAPTER 3 
METHODOLOGY 
 Since iCVH metrics were first introduced in the literature in 2010, Chapter 2 above 
highlighted several gaps in knowledge regarding familial aggregation and the relationships 
with iCVH metrics. Scientific evidence in the last decade suggests that development of 
atherosclerosis begins in childhood (Hayman & Worel, 2015; Juonala et al., 2010; Loria et 
al., 2007), however, specific cross-sectional and longitudinal data on the association of 
familial aggregation of combined iCVH metrics and CVD outcomes (Loria et al., 2007) is 
currently lacking. Moreover, there has not been studies of parent-offspring dyads to 
empirically quantify the association of iCVH longitudinally in reducing the burden of 
incident CVD and CVD-DALYs. This dissertation examined time trends of iCVH metrics 
and burden of CVD with the goal of  informing the association of familial aggregation of 
iCVH using FHS data (Feinleib, Kannel, Garrison, McNamara, & Castelli, 1975; Kannel, 
Dawber, Kagan, Revotskie, & Stokes, 1961).  
Data from the Original and Offspring Cohorts of the FHS were analyzed to 
elucidate intergenerational patterns of health behaviors between parents and their 
offspring. Framingham Heart Study is a unique epidemiological study that has contributed 
substantially to the current knowledge of cardiovascular diseases, enrolling and 
meticulously following three generations of Framingham residents in Massachusetts (see 
Figure 3.1). The FHS has contributed to a cutting-edge understanding of CVD risk factors 
and heart disease treatment due to its comprehensive recording of physical, phenotypic 
and biological traits (Tsao & Vasan, 2015). The design of FHS is described in detail 
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elsewhere and is one of the longest  multi-generation studies (Kannel et al., 1961). The 
Original Cohort was recruited in 1948 with a sample size of 5209 persons aged 28-62 
years (Dawber, Meadors, & Moore, 1951). The second-generation cohort, Offspring 
Cohort, is comprised of children and spouses of children from the Original Cohort. The 
Offspring Cohort was enrolled in 1971 and included 5124 participants (Feinleib et al., 
1975). Further in 2002, the third generation of 4095 adults having at least one parent in 
the Offspring Cohort was started to explore contributions of inheritance or genetic 
patterns to CVD development (Tsao & Vasan, 2015).  
 
Figure 3. 1. Time course of enrollment of the cohorts within the FHS. Adapted from “Cohort 
Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular 
epidemiology,” by C. W. Tsao, and R. S. Vasan, 2015, International Journal of 
Epidemiology, 44(6), 1800–1813. https://doi.org/10.1093/ije/dyv337 
 
Study Population 
 Framingham Heart Study participants are community dwelling; most of whom were 
selected using systematic random sampling of residents of Framingham, Massachusetts, with 
a population of 10, 000 at its inception.  Individuals or selected households and all family 
residents were invited to participate. A response of 4, 469 (68.7%) was achieved and n=888 
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volunteers were included to achieve the desired sample size. More than one half of the 
Original Cohort participants were women (Mahmood, Levy, Vasan, & Wang, 2014).  
 More than two out of three (~ 66%) of the Offspring Cohort participants are biologic 
offspring of the Original Cohort (Feinleib et al., 1975). These parent-offspring dyads were 
the focus of this analysis. At enrollment, Offspring Cohort participants, the children of 1644 
spouse pairs were aged 12-60 years. Framingham residents were exclusively white at the 
time of initiation. The lack of ethnic diversity of Framingham has been recognized as a 
limitation of the study; therefore, the study is not representative of the general population. 
However, FHS has contributed to science that is applicable among diverse multiethnic 
groups and some of the findings such as CVD risk factors are similar to other multiethnic 
cohort studies (Tsao & Vasan, 2015). Regarding social diversity, the participants  were from 
all social classes (Northwestern University, 2013; Tsao & Vasan, 2015). Framingham city 
was selected for this epidemiological study after many considerations; one indicated that the 
region had successfully completed a six-year country’s first community study of tuberculosis 
which began in 1917. The Framingham community had also demonstrated a goodwill for 
population-based research and was accustomed to group approach for solving their problems. 
Taken together, the characteristics of Framingham  provided such an environment and one 
with strong potential  to enroll sufficient participants  in a long-term study (Dawber et al., 
1951). 
Standardized and Systematic Data Collection 
Most of the examination cycles in the FHS are done every 2 years which is 
coordinated by a team of staff including examining physicians, clinic nurses, statisticians, 
 37 
 
imaging and laboratory technicians, among others (Dawber et al., 1951). Family and 
medical history, physical examination targeting CVD, smoking history, dietary intake, 
physical activity, anthropometrics, blood pressure, hemoglobin A1c, lipids and CVD 
imaging and pulmonary function test are systematically collected using standardized 
protocols, usually at onsite locations such as elderly, home- or nursing homes (Tsao & 
Vasan, 2015). Interim questionnaires regarding medical and family history are usually 
mailed in between examinations, while further information is obtained via phone calls. 
Regular surveillance of the subjects is done to identify specific CVD events such as 
angina pectoris, myocardial infarction, heart failure and stroke or cerebrovascular disease. 
The 22-year lapse between the two cohorts strategically places the offspring to be 
examined at approximately the same ages as their parents (Feinleib et al., 1975; Tsao & 
Vasan, 2015).  
Selection of Exam Cycles for Familial Aggregation Analysis 
Table 3.1 below shows the mean age distributions for each exam cycle for the 
Original and Offspring Cohorts as well as the number of participants attending each exam 
cycle. The rationale for selecting exam cycles was to achieve approximate similarity in 
the mean age between the two cohorts at the paired exam cycles. The exam periods 
selected for this study are as follows: (1) Original Cohort’s exams 1, 3, 5, 7, 9, 11 (mean 
ages 44, 48, 52, 55, 59, 62 years, respectively), and (2) Offspring’s Cohort’s exams 2, 3, 
4, 5,  6, 7 (mean ages 44, 48, 52, 55, 59, 62 years, respectively) with a mean age range of 
3-4 years between the exam periods. Notable, the distribution of age at specific-exam 
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cycles was generally comparable and is important for parent-offspring comparison of 
different CVD profiles.  
Table 3. 1  
Framingham Heart Study Exam Dates and age ranges 
Original Cohort Offspring Cohort 
Exam 
Exam 
Dates 
Age 
Range 
Mean 
Age 
Attendees Exam 
Exam 
Dates 
Age 
Range 
Mean 
Age 
Attendees 
Exam1 
 1948- 
1953 
28-74 44 5209 Exam2  1979-1983 17-77 44 3863 
Exam3 
 1952- 
1956 
32-67 48 4416 Exam3  1983- 1987 18-77 48 3873 
Exam5 
 1956- 
1960 
37-70 52 4421 Exam4  1987- 1991 22-81 52 4019 
Exam7 
 1960- 
1964 
40-74 55 4191 Exam5  1991- 1995 26-84 55 3799 
Exam9 
 1964- 
1968 
44-78 59 3893 Exam6 
 1995- 
1998 
29-86 59 3532 
Exam11 
 1968- 
1971 
49-81 62 2955 Exam7 
 1998- 
2001 
33-90 62 3539 
 
Table on matched exam pairs of FHS-Original and Offspring Cohorts. Adapted from the 
“Framingham Heart Study-Cohort (FHS-Cohort)” by American Heart Association, 2017. 
Retrieved from https://www.framinghamheartstudy.org/researchers/description-
data/data/tableofexams.pdf  
Familial Aggregation Analysis 
 The final sample size for the familial aggregation analysis of iCVH was determined 
from the number of 1644 father and mother pairs with biological children also enrolled in the 
Offspring Cohort Study (see Table 3.2). A parent in this dissertation was therefore a 
biological father and/or mother of an offspring. Family members were linked using a family 
identification (famID) number and each participant has their own unique ID number linking 
their individual data across exams as well as to the CVD events and survival files in FHS.  
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Table 3. 2  
Sampling Frame of the Offspring Cohort 
Total spouse pairs in Original Cohort 1644 
Spouse pairs with ≥1 children 1387 
Spouse pairs with no children 227 
Unknown pairs 30 
Individuals with no spouse in Original Cohort 1921 
Individuals with CHD/lipid abnormality &≥1 child 330 
Individuals with ≥1 offspring volunteer 163 
Adapted from “The Framingham Offspring Study. Design and preliminary data,” by Feinleib, M., 
Kannel, W. B., Garrison, R. J., McNamara, P. M., & Castelli, W. P.,1975. Preventive Medicine, 4(4), 
518–525 
Data for Analyzing Cardiovascular Disease Burden 
 Cardiovascular disease burden (CVD-DALYs), CVD-survival free period, CVD 
events and mortality rates were derived from the FHS Sequence of Events (SOE), and 
Survival Files and Follow-up for Cardiovascular Events files (BioLINCC, 2017), and the U.S 
official life expectancy data and disability weights were derived from the GBD 2016 study 
and the National Center for Health Statistics (GBD 2016 SDG Collaborators, 2017; National 
Center for Health Statistics, 2017).  
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Table 3. 3  
Ideal Cardiovascular Health Metrics using AHA criteria for adults ≥20 years 
Blood Pressure Ideal [2] <120/<80 mmHg 
Intermediate [1] SBP 120–139 or DBP 80–89 mmHg 
Poor [0] SBP≥l40 or DBP≥90mmHg 
Physical Activity Ideal [2] ≥150 min/wk M or ≥75 min/wk V or ≥150 min/wk M+V 
Intermediate 1–149 min/wk M or 1–74 min/wk V or 1–149 min/wk  M+V 
Poor [0] None 
Cholesterol Ideal [2] <200 mg/dL 
Intermediate [1] 200–239 mg/dL 
Poor [0] ≥240 mg/dL 
Healthy Diet Ideal [2] 4–5 components 
Intermediate [1] 2–3 components 
Poor [0] 0–1 component 
Healthy Weight Ideal [2] <25 kg/m2 
Intermediate [1] 25–29.9 kg/m2 
Poor [0] ≥30 kg/m2 
Smoking Status Ideal [2] Never or quit > 12 months 
Intermediate [1] Former ≤12 months 
Poor [0] Current smoker 
Fasting/Random Blood 
Glucose 
Ideal [2] <100 mg/dL OR <140 mg/dL 
Intermediate 100–125 mg/dL OR 140-199 mg/dL 
Poor [0] ≥ 126 mg/dL OR ≥ 200 mg/dL 
  Key: SBP, Systolic blood pressure; DBP, diastolic blood pressure; wk, week; M, moderate; V, vigorous; 
Adapted from “2017 Statistical Fact Sheet: Cardiovascular health” by AHA, 2017. Retrieved from 
https://healthmetrics.heart.org/wp-content/uploads/2017/06/2017-Statistical-Fact-Sheet-ucm_492104.pdf 
 
Inclusion and Exclusion Criteria 
 Participants were included if aged 20 years and older at the first eligible exam period. 
Offspring were required to be biological children of the parents even though it was not a 
requirement that the parents should be married to each other or live together for the entire 
offspring’s childhood (≤18 years). Participants were included if they had at least five of the 
following variables recorded at each of the exams for deriving of iCVH metrics: (1) smoking, 
(2) body mass index, (3) physical activity, (4) dietary intake of vegetables and fruits or other 
recommended dietary components, (5) total cholesterol, (6) blood pressure and (7) blood 
glucose as shown in Table 3.3 below. It is recommended to conduct multiple imputation if 
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more than 10% but less than 25% of the participants had missing covariates to preserve 
power (Lodder, 2013; Mukaka et al., 2016; Pedersen et al., 2017); however, most of the 
variables had less than 10% missing values necessitating a complete case analysis (see 
appendix for table of missing values). 
Independent Variables and Operational Definitions 
 The main exposure variable was the  iCVH metric for the parents derived from seven 
(or five depending on which variables were missing) variables, namely; smoking, body mass 
index, physical activity, healthy diet, total cholesterol, blood pressure and blood glucose 
(AHA, 2017b). Idela cardiovascular health was defined using the seven metrics on a score of 
0=poor, 1= intermediate, 2=ideal (Lloyd-Jones et al., 2010) as shown in Table 3.3 and 
operationalized as described in the inclusion criteria. Smoking and physical activity and diet 
were self-reported in FHS using a technician-administered questionnaire. Cigarette smoking 
history was collected for most exams and was mainly recorded as current smoker if smoked 
within a year and not a smoker if quit for more than a year or never smoked  (BioLINCC, 
2017). The smoking variables were generated from questionnaire data regarding the 
participants’ smoking history and classified using iCVH criteria. Participants who answered 
as currently smoking cigarettes were classified as “poor”, former smokers or who quit 
smoking in less than 12 months were classified as “intermediate”, those who never smoked 
or quit smoking more than 12 months were classified as “ideal”.  
 Physical activity questions were based on hours spent sleeping, resting, in slight, 
moderate or heavy activity on an average day. Physical activity score was calculated using 
previously suggested methods for use in FHS physical activity data (Kannel et al., 1961). 
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Minutes spent on each activity was multiplied by the oxygen requirement or metabolic cost 
for that activity as described by Kannel (Kannel et al., 1961). This method assigns weights 
for different activities such as sleep (1.0), sedentary (1.1), slight activity (1.5), moderate 
activity (2.4), heavy activity (5) in the formula: Physical activity score= (1.0 x hsleep) + (1.1 x 
hsedentary) + (1.5 x hslight) + (2.4 x hmoderate) + (5.0 x hheavy) to derive a physical activity score 
(on a continuous scale, with no SI units). This methodology on calculating physical activity 
has been used elsewhere in other studies involving FHS data (Jonker et al., 2006; Shortreed, 
Peeters, & Forbes, 2013). Physical activity score was collapsed into three categories less than 
30 for poor, 30-33 for intermediate and greater than 33 for ideal physical activity levels as 
used elsewhere (Jonker et al., 2006; Shortreed et al., 2013). This scale has been used 
effectively among FHS participants and has been shown to be appropriate for physical 
activity score derivation in this population (Shortreed et al., 2013). 
 A healthy diet was defined as the top 40% of a dietary score and is composed of low 
glycemic load, high cereal fiber, high folate, high marine omega-3 fatty acid, a high 
polyunsaturated to saturated fat ratio, and low trans-fat content  (Lloyd-Jones et al., 2010). 
Data for diet as defined in this study was available in exams 20, 21, 22 for Original Cohort 
(parents) and exams 3, 5, 6, 7 for Offspring Cohort. Healthy diet was derived from five food 
groups according to AHA criteria as follows: (1) dairy products, (2) meats, (3) saturated fats, 
(4) vegetable or fruit intake and (5) cereals (AHA, 2018c). The dietary components were 
collected using the Framingham Diet Composite Table and entered in the FHS dataset 
(Mann, Pearson, Gordon, & Dawber, 1962). If no dietary components were available in any 
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of the study exams, only the available iCVH metrics (mostly five metrics) were used to 
calculate iCVH. 
Three blood pressure readings were taken (using Baumanometer 300 model and Litman 
stethoscope: Classic II 3M) on each participant, initial one by the nurse on admission and the 
two-final blood pressure measurements by the examining physician as recorded in the FHS 
30-year protocol section. Blood pressure categories were calculated from an average of the 
three blood pressure readings (one by the nurse on admission and the two-final blood 
pressure measurements by the examining physician) for each exam cycle. The participants 
were seated with arm at the heart level (National Heart, Lung, and Blood Institute, 2017). 
Normal blood pressure (“ideal”)  was defined as ≤120/80mm Hg to be consistent with the 
current hypertension guidelines and iCVH definition (AHA, 2017c, 2017b). Body weight 
was measured using Detecto Worcester scale, Co, Inc. and recorded in pounds. Participant’s 
height was measured using a Stadiometer, barefoot or wearing thin socks and recorded  in 
inches (BioLINCC, 2017). Body mass index was calculated in FHS, similar to other 
epidemiological studies, as weight in kilograms divided by height in meters-squared (kg/m2). 
Serum cholesterol was determined using colorimetric method but the measurement 
method was later changed after exam 2 in 1952 to use the Abell-Kendall method 
(BioLINCC, 2017). Blood was collected in oxalate tube and centrifuged at 5000 rpm for 
hematocrit and hemoglobin measurement. Blood glucose was recorded in mg/100ml, as the 
amount of glucose present in whole blood from the oxalate potassium solution using Nelson 
method (BioLINCC, 2017; National Heart, Lung, and Blood Institute, 2017). Blood glucose 
measures were recorded as fasting and/or random blood sugar. In this case, blood glucose 
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was not necessarily required to have been entered in fasting status for calculation of iCVH, 
but fasting blood glucose values were preferred where available.  
 Other covariates included were offspring age at the exam cycle, sex, education and 
level of income. All self-reported data were collected using a technician-administered 
questionnaire (BioLINCC, 2017). Parental and offspring education and occupation has been 
previously used in FHS to calculate the relationship between socioeconomic position (SEP) 
and incidence of coronary heart disease among the Offspring Cohort (Loucks et al., 2009). 
Inclusion of education and income in this intergenerational study is important because the 
two factors (education and income) have been implicated as the main socio-determinants of 
health that are involved in the transfer of health from parents to offspring (Loucks et al., 
2009). Low level of education and low income in this case are viewed as cumulative 
exposures to socioeconomic disadvantage over the lifespan that leads to CVD later in life, for 
individuals and/or from one generation to another.   
Dependent Variables and Operational Definitions 
  Offspring iCVH and CVD DALYs were the main dependent variables. Ideal 
cardiovascular metrics for offspring were operationalized as described for parents. 
Cardiovascular disease was defined using the FHS criteria to include SOE codes for coronary 
heart disease, intermittent claudication, congestive heart failure, stroke or transient ischemic 
attack (BioLINCC, 2017). Diagnosis of coronary disease in FHS was adjudicated based on 
medical records and agreed upon by a panel of three cardiologists. Stroke events were 
confirmed if participants demonstrated abrupt onset hemiparesis or aphasia, computed 
tomography scan (CT) scan was used to confirm the diagnosis (Tsao & Vasan, 2015). 
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Intermittent claudication was mostly subjectively diagnosed when reported as cramping 
discomfort in calf muscles with walking and relieved by rest and then physician physical 
examination was completed to confirm diagnosis.  Diagnosis of congestive heart failure in 
FHS was made using criteria of two major episodes of: either paroxysmal nocturnal dyspnea, 
jugular vein distention, acute pulmonary edema, or one major and two minor events of 
bilateral ankle edema, night cough, dyspnea on ordinary exertion, hepatomegaly, pleural 
effusion (BioLINCC, 2017; Tsao & Vasan, 2015). 
 Disability-adjusted life years were used to estimate the burden of CVD for parents 
and offspring as described later in this chapter. The baseline visit was the first selected exam 
cycleof each cohort (i.e exam 1 for parents and exam 2 for offspring). Cardiovascular disease 
DALYs (see Figure 3.9) of each cohort was calculated for each exam and stratified by iCVH 
metrics. Trend of DALYs lost due to CVD for each cohort were presented at each exam 
cycle (Tables 4.13a&b). Further details for DALYs calculation are provided in the data 
analysis section. 
Human Subject Consideration (Institutional Review Board-IRB) 
 Institutional ethics approval was granted by the University of Massachusetts Boston 
under the definition of a human subject research at 45 CFR 46.102. In addition, further 
approval was granted by the National Heart, Lung, and Blood Institute (NHLBI) and signed 
relevant Research Distribution Agreement (RMDA) materials. Framingham Heart Study is 
an existing public dataset of individuals who have provided informed consent. The data of 
this study are de-identified so that no information such as name or any other personally 
identifiable information can be accessed.  
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Statistical Analysis  
The path diagram or schematic analytic model below (Figure 3.2) is used to depict the 
conceptual framework of how parental iCVH metrics influence those of their offspring. 
 
Figure 3. 2 Path diagram showing intergenerational association of iCVH metrics between 
parents to offspring. 
Key: variables=EDU (education), INC (income), PA (physical activity), DT (diet), SMK 
(smoking), BMI (body mass index), BP (blood pressure), FPG (blood glucose), CHOL 
(cholesterol); “X” o Offspring); “X” p (Parents), iCVH (iCVH). 
 The model includes two main exogenous variables namely education and income 
(assessed anytime between exams 1-7 in both cohorts). Education variable is the main driving 
force, with some modifying effect on income. The emphasis of this model is the influence of 
parent’s health behaviors (assessed at exam periods 1, 3, 5, 7, 9, 11) and those of their offspring 
(assessed at exam periods 2, 3, 4, 5, 6, 7). Parent’s smoking status (SMKp), physical activity 
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(PAp) and diet (DTp) are hypothesized to directly influence respective offspring health 
behaviors [smoking behavior (SMKo), physical activity (PAo) and diet (DTo), with the main 
driving factor being parents’ education status (EDUp). Progressively, the model hypothesizes 
that offspring’s behaviors [smoking behavior (SMKo), physical activity (PAo) and diet (DTo)] 
influence their own physiological factors (BMIo, BPo, CHLo, FPGo). There is a complex 
interrelationship among offspring’s physiological factors, but for the ease of illustrating the 
relationships, an abbreviated explanation is provided below. Combined effect of offspring’s 
blood pressure (BPo), blood glucose (FPGo), body mass index (BMIo) and cholesterol levels 
(CHLo) contribute directly to the offspring’s iCVH status (iCVHo), which further influences 
their total cardiovascular disease burden (CVD DALYSo). Additively, the role of familial 
genetics is depicted through the parental physiological factors (BMIp, BPp, CHLp, FPGp) 
which directly influence the offspring’s physiological factors (BMIo, BPo, CHLo, FPGo). This 
effect modulates the risk of CVD by either increasing or reducing offspring iCVH, with 
subsequent effects on offspring CVD DALYs. In summary, the probability of achieving an 
iCVH (seven health metrics) among the offspring is primarily a function of parental iCVH 
metrics (behavioral and biomarkers) and socioeconomic status 1) iCVHk = a + biCVHp + 
cEDUo + Σoffspring{age; sex}+ εk , where offspring’s iCVH health (iCVHo) hypothetically 
depends on parents’ iCVHp and the offspring’s education (EDUo), controlling for age and sex 
of the offspring. 
 Statistical analysis of specific aim 1. Aim 1 examined the association of offspring’s 
iCVH and their parents at comparable mean age for the selected exam cycles (where 
offspring iCVH dependent variable and parent iCVH as the main explanatory variable). Both 
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offspring and parent iCVH were categorized as poor (0), intermediate (1) and ideal (2) as 
shown in Table 3.3 and as a continuous iCVH variable on a scale of 0 to 14, meaning than 
each iCVH metric contributes a maximum of two points, multiplied by the seven to make 14 
as maximum point. Testing of normality assumption of the linear regression model was 
conducted using Q density plot and Q-Q plot of residuals in STATA. 
 Statistical analysis for aim 1 hypothesis 1A. Hypothesis 1A was to determine 
whether iCVH metrics for parents will be positively correlated with that of their offspring at 
similar mean age. Pearson correlation coefficients were used to assess linear patterns of 
iCVH at each examination to determine whether the correlation between parent iCVH and 
offspring iCVH becomes stronger or weaker with time and check the similarities of 
correlations at each exam cycle. A correlation coefficient matrix table was generated as 
shown in sample Table 3.4, one matrix for parents (mother and/or father), offspring with 
their mothers and another matrix for offspring with their father with direct correlation 
coefficients r12, r33, r54, r75, r96 and r117 as period specific coefficients and off-diagonal 
partial correlations r14, r35, r56 and r77. 
 While the interpretation of diagonal correlation coefficients r12, r33, r54, r75, r96 and 
r117 is straightforward, they represent “age-contemporaneous” exam cycles when each 
cohort had similar age distribution. On the other hand, off-diagonal partial correlations r14, 
r35, r56 and r77 represent the nature of the correlation when the Original Cohort and 
Offspring Cohort are mismatched for age distribution, i.e., when the cohorts are “age non-
congruent”. This hypothesis generating analysis was designed to reveal whether correlations 
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are unstructured, remain constant, or decline with widening age gap between parent and 
offspring, i.e., constant, autoregressive, compound symmetric (Kincaid, n.d.).  
 Table 3. 4  
Pearson Correlation coefficient matrix for parents and offspring iCVH 
 
 Mean iCVH Father/Mother   
Offspring iCVH at 
exam 
iCVH exam 1 iCVH exam 3 iCVH exam 5 iCVH exam 7 iCVH exam 9 iCVH exam 11 
iCVH exam 2 r12      
iCVH exam 3 r13 r33     
iCVH exam 4 r14 r34 r54    
iCVH exam 5 r15 r35 r55 r75   
iCVH exam 6 r16 r36 r56 r76 r96  
iCVH exam 7 r17 r37 r57 r77 r97 r117 
 Mean iCVH Mother   
Offspring iCVH at 
exam 
iCVH exam 1 iCVH exam 3 iCVH exam 5 iCVH exam 7 iCVH exam 9 iCVH exam 11 
iCVH exam 2 r12      
iCVH exam 3 r13 r33     
iCVH exam 4 r14 r34 r54    
iCVH exam 5 r15 r35 r55 r75   
iCVH exam 6 r16 r36 r56 r76 r96  
iCVH exam 7 r17 r37 r57 r77 r97 r117 
 Mean iCVH Father   
 iCVH exam 1 iCVH exam 3 iCVH exam 5 iCVH exam 7 iCVH exam 9 iCVH exam 11 
iCVH exam 2 r12      
iCVH exam 3 r13 r33     
iCVH exam 4 r14 r34 r54    
iCVH exam 5 r15 r35 r55 r75   
iCVH exam 6 r16 r36 r56 r76 r96  
iCVH exam 7 r17 r37 r57 r77 r97 r117 
 
 Power and sample size for aim 1 hypothesis 1A. Studies have shown some parent-
offspring Pearson correlations between some iCVH metrics such as diet, physical activities 
ranging from 0.24-0.52 (McGowan et al., 2013; Storti, Kristi Leigh, 2007; Wang, Beydoun, 
Li, Liu, & Moreno, 2011; Yee, Lwin, & Ho, 2017). It is assumed that relationship between 
parents and children will follow a similar pattern. Table 3.5 below shows different power 
estimations for detecting a Cohen’ d of 0.10 using samples ranging from 800 to 1500 at 0.05 
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and 0.01 significance levels. Using two-tailed t-test for correlation, a sample size of 800 
parents and offspring will detect significant correlations between parents and offspring, with 
power of 81% and at a small effect size of 0.1. An excellent power of 82% and small effect 
size of 0.10 will also be achieved with a sample of N=1200 at a lower significance level of 
0.01. 
Table 3. 5  
Power calculation for hypothesis 1A 
α/cohen’s d n=800 n=1000 n=1200 n=1500 
0.05/0.10 Power=0.81 Power=0.89 Power=0.94 Power=0.97 
0.01/0.10 Power=0.60 Power=0.72 Power=0.82 Power=0.91 
 
 Statistical analysis for aim 1 hypothesis 1B. Hypothesis 1B examined the 
relationship between Parent iCVH and Offspring iCVH at similar mean age using linear 
regressions with the Offspring iCVH as the dependent variable and the Parent iCVH as the 
main exposure variable. Exploratory data analysis was used to determine whether iCVH was 
normally distributed or skewed. Model 1 was comprised of a simple linear regression 
analysis of the Offspring’s iCVH as dependent variable and the iCVH for the parents as the 
independent variable.  Model 2 was comprised of the same model as Model 1 but adjusted 
for the offspring’s exam-specific covariates (age, sex, income, education level), with a 
general regression equation: iCVHo = a + β1iCVHp + β2Education + {β2Sex; β3Age } + εk. 
This model asserts that an offspring’s iCVH (iCVHo) depends on the parents’ iCVH 
(iCVHp) and offspring’s education, controlling for age and sex of the offspring. Testing of 
normality assumption of the linear model was done using Q density plot and Q-Q plot of 
residuals. Income variable was dropped from the model since it did not yield any significant 
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relationship. All regression equations were run with complete case analysis since most of the 
variables had more than 25% missing values.  
 Supplemental Statistical analysis for aim 1 hypothesis 1B. As a supplement to 
linear regression, Models 1 and 2 were similarly implemented using ordered logit model also 
known as the proportional odds model (Peterson & Harrell, 1990). In proportional odds 
modeling, the Offspring’s iCVH (dependent variable) and Parents’ iCVH (independent 
variable) were transformed to an ordinal variable to conform to AHA classification of iCVH 
into three levels, coded as “poor” [0], “intermediate” [1] and “ideal” [2]. The proportional 
odds model is suited for the analysis of ordinal response variables, assuming that the slopes 
among the ordered levels are parallel. This assumption was assessed in preliminary analyses, 
using Brant test and consequently confirmed using gologit2 command in STATA (Williams, 
2018). The tests showed that overall, there was no violation of the parallel regression 
assumption.  Details on the statistical theory behind the partial proportional odds model can 
be found in several sources (Ananth & Kleinbaum, 1997; Williams, 2018). The STATA 
command ologit was used to fit the proportional odds model (Williams, 2006), which set the 
“poor” iCVH category as the referent category as opposed to the gologit2 command which 
set “ideal” category as referent category. Results were however checked to determine if there 
were substantial differences between the two estimation commands. Model 1 was not 
adjusted for any covariates, but Model 2 was adjusted for the offspring’s covariates (age, sex, 
education level). To account for correlation due to familial clustering, regression models 
were run using the ‘cluster’ option in STATA with Family ID as the cluster variable. 
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 Power and sample analysis for aim 1 hypothesis 1B. Previous studies have 
documented positive linear relationships between some of the iCVH metrics among parents 
and offspring. For instance, in one study, regression coefficients for offspring and parent 
were 0.213, 0.144, 0.231, 0.038 for BMI, systolic blood pressure, total cholesterol, glucose, 
respectively (Vik, Romundstad, Carslake, Smith, & Nilsen, 2014).  To be able to detect a 
Cohens d of 0.10 using a two-tailed t-test for correlation at α =0.05 significance level, a 
minimum sample size of 800 parents and offspring is required to detect statistically 
significant correlations between parents and offspring achieves 81% power. A sample size of 
1200 achieves 82% power at a conservative significance level of α =0.01 can also be 
achieved with a sample of 1200 (see Table 3.6 below). 
Table 3. 6  
Power calculation for hypothesis 1B 
α/cohen’s d n=800 n=1000 n=1200 n=1500 
0.05/0.10 Power=0.81 Power=0.89 Power=0.94 Power=0.97 
0.01/0.10 Power=0.60 Power=0.72 Power=0.82 Power=0.91 
 
 Statistical analysis of specific aim 2. Aim 2 compared iCVH and CVD DALYs 
between parents and offspring at exam cycles where distribution of age at specific exam 
cycles are generally comparable. The following hypotheses were tested: (1) Hypothesis 2A, 
accounting for age, sex, education and income, the parents’ and offspring’s iCVH metrics 
will be positively associated with CVD DALYs respectively and (2) Hypothesis 2B, 
offspring of parents with lower iCVH will have higher mean CVD DALYs compared to the 
mean CVD DALYs for offspring of parents with higher iCVH. 
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 Statistical analysis of hypothesis 2A. Hypothesis 2A proposes that parents’ and 
offspring’s iCVH metrics will be positively associated with their respective CVD DALYs at 
each exam cycle. Separate regressions were run for the parents and for the offspring at each 
of the six exam cycles: (1) Model 1=simple regression for CVD DALYs as outcome variable 
and iCVH (continuous variable), (2) Model 2=multivariate model as in 1 above controlling 
for age, education, sex and income, and (3) iCVH as categorical (“poor” [0], “intermediate” 
[1] and “ideal” [2]) as follows: Model 1=simple regression for CVD DALYs as outcome 
variable;  iCVH adjusted for age and Model 2=multivariate model as in 1 above controlling 
for age, education, sex and income. Linear trends regarding the effect of iCVH were assessed 
across exam cycles by plotting the regression coefficients of iCVH over time.  
 Statistical power and sample size for hypothesis 2A. No study was identified to 
describe the relationship between heart-healthy behaviors and CVD DALYs averted.  
However, it is assumed that for every one-unit increase in iCVH, there will be a reduction on 
CVD DALYs based on prior research on disease burden (Global Burden of Cardiovascular 
Diseases Collaboration et al., 2018). Table 3.7 below shows different power estimations for 
detecting a Cohen’ d of 0.10 using samples ranging from 800 to 1500 at α =0.05 and α =0.01 
significance levels. For example, a sample size of 800 will achieve 81% power for detecting 
a Cohen’s d of 0.10 at α =0.05. 
Table 3. 7  
Power calculation for hypothesis 2A 
α/cohen’s d n=800 n=1000 n=1200 n=1500 
0.05/0.10 Power=0.81 Power=0.89 Power=0.94 Power=0.97 
0.01/0.10 Power=0.60 Power=0.72 Power=0.82 Power=0.91 
 
 54 
 
 Statistical analysis for aim 2 hypothesis 2B. To assess whether offspring of parents 
with lower iCVH will have higher mean CVD DALYs compared to the mean CVD DALYs 
for offspring of parents with higher iCVH, the following was done. A two-sample t-test was 
used to compare the means for parents vs. offspring: iCVH and CVD DALYs. Additionally, 
two-sample t-test was used to analyze subgroups of CVD DALYs for offspring of parents 
with high (>7) and low (≤7) iCVH [or high (>5) versus low (≤5) parental iCVH if missing 
two iCVH variables).  
 Calculation of DALYs, YLDs, and YLLs. First, sex-individual-specific CVD 
DALYs, YLDs, and YLLs were calculated for each eligible parents and offspring. The 
relation of DALYs to YLDs and YLLs is DALYs=YLD+YLL (see Figure 3.1). In this 
equation individual YLD is calculated as the number of cases=1 (since the outcome event is 
only “CVD” for each individual) multiplied by years lived until death, then multiplied by 
CVD disability weights (1X years until death X CVD disability weight); YLL was calculated 
as the age at death due to CVD multiplied by remaining years if someone reached the 
maximum life expectancy (i.e age at death X remaining life expectancy at the age of death) 
(Devleesschauwer et al., 2014). The aggregate CVD disability weight of 0.276 was derived 
from Global Burden of Disease Study 2017, and calculated as an average of disability 
weights of five most common CVDs (myocardial infarction, DW=0.432; stroke, DW=0.588; 
heart failure=0.179, intermittent claudication=0.014; angina, 0.167) (GBD 2017, 2017).  
 The 2016 age-standardized maximum life expectancy for US population at birth was 
used to calculate the maximum expected life expectancy for each cohort, i.e 81 years for 
females and 76 years for males (National Center for Health Statistics, 2018). Rationale for 
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using 2016 life expectancy is given at the analysis section of CVD DALYs. Exploratory data 
analysis was used to determine whether DALYs are normally distributed. Four hypothetical 
examples as shown in Table 3.8 below illustrate the calculation of DALYS assuming the 
2016 US life expectancy. The four hypothetical individuals are assumed to experience CVD 
events at different ages. Years of Life Lost (YLLs)=Life Expectancy (LE)-Age died; Years 
Lived with Disability (YLDs)= (1 X [years until death] X [CVD disability weight]); and 
CVD DALYs =YLLs +YLDs.   
Table 3. 8  
Example of DALYs calculation using CVD disability weights (DW) of 0.276 
 Female 
YOB 
(I) 
YR CVD 
DX (II) 
YR CVD 
death 
(III)/end 
f/up 
Expected 
LE (I+81) 
(IV) 
YLL 
(IV-III) 
YLD= [III-
II] *DW 
 
DALYs= 
YLL+YLD 
A  1900 1956 1975 1981 6 5.2 11.5 
B 1922 1970 1991 2003 12 5.8 17.5 
C 1890 1948 1990 1971 0 11.5 11.5 
D 1950 1988  1991 2031 0 3 3 
*LE, life expectancy; Equations: YLL= Life Expectancy (LE)- Year died/end of follow- 
up; YLD=1 X duration with CVD till death X disability weight; DALYs=YLD+YLL. 
Note end of follow-up for parents=1991, for offspring is 2014; YLLs less than zero were 
coded as zero 
 The DALYs calculations were done in way that it would be possible to compare equal 
follow-up times for parents and offspring. Considering the available CVD events follow-up 
time for the offspring of 43 years (1971-2014), parents follow-up time was truncated at the 
year 1991 (meaning parents alive at 1991 mark was coded as end of follow-up even if they 
continued to be followed-up for CVD events). Decision to use this balanced method was 
based from Struijk and colleagues (method 4 pg.3) who recommended an elaborate method 
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of calculating individual-specific life expectancies in a cohort data as opposed to the most 
common method of calculating population-based life expectancy (Struijk et al., 2013). This 
method is appropriate as it estimates life expectancy at attained age (age of death or end of 
follow up) and was found to be most accurate for calculating the number of years lost giving 
a variable age and variable reference year for individual participants a cohort dataset 
expectancy (Struijk et al., 2013). 
 Statistical power and sample size for hypothesis 2B. Previous studies have reported 
that the mean CVD DALYs in the United States was 6231 per 100, 000 in 2005 and 5178 per 
100, 000 in 2015 (GBD 2015 DALYs and HALE Collaborators, 2016). Assuming a sample 
ratio of 1:1 between parents and offspring, alpha of 0.05 and a Cohens d of 0.10, a sample 
size of 1612 can detect a significant mean CVD DALYs differences with a power of 81% 
and SD of 0.5. 
Table 3. 9  
Power calculation for hypothesis 2B 
α/cohen’s d n=1612 n=2032 n=2472 n=2952 
0.05/0.10 Power=0.81 Power=0.89 Power=0.94 Power=0.97 
Sensitivity Analysis 
 This study employed several levels of sensitivity analysis. The most outstanding 
sensitivity analyses include running several regression equations at each exam cycle for 
Original and Offspring Cohorts using iCVH as continuous variables. Conversion of iCVH 
metrics into binary variables 0 or 1 (low iCVH≤5=0 and high iCVH>7=1) and ordered 0, 1, 2 
categories also provided comparative analysis. Burden of CVD calculated from DALYs 
averted or incurred from each increment of iCVH also provided information on how iCVH 
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metrics drive CVD burden and compared CVD DALYs results with and without disability 
weights.  
 In this chapter, the FHS and how the study is an ideal setting for the proposed 
analysis was described. Exam cycles at which the Offspring and Original Cohort had similar 
age distribution were identified. The outcome variable for Aim 1, iCVH for offspring as well 
as the iCVH for the parents and their derivations were described. The outcome variable for 
Aim 2, CVD DALYs and their derivations were also described. Proposed statistical method 
for addressing Aims 1 and 2 were provided together with a sensitivity analysis. Next, in 
Chapter 4, statistical results for Aims 1 and 2 will be summarized and discussed in Chapter 5.  
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CHAPTER 4 
RESULTS 
 Chapter 4 presents statistical results for Aims 1 and 2. Aim 1 examined the 
association of iCVH health between parents and offspring assessed at selected exam 
cycles at which both cohorts had similar age distribution. Aim 2 compared iCVH and 
CVD DALYs between parents and offspring at paired exam cycles (Table 3.1). Offspring 
participants were recruited from 1644-spouse pairs of Original Cohort at the onset. In 
preparing the data before statistical analysis, the family ID was used to link the data for 
each offspring to the data of the parents. Each record in the analysis dataset represents a 
unique offspring participant. The parents’ data was merged to each corresponding 
offspring such that in families with multiple children, the data for the parents was 
replicated in the records for all their children. Original Cohort participants [parents’ 
cohort] with no offspring were excluded.  
 Paired exam cycles were selected such that mean age of parent cohort was similar to 
the Offspring Cohort, a total of six exam cycles for each cohort were paired as shown in 
Table 1 in the Methods section. Note that the parent/offspring exam cycles (1/2 [mean ages 
44/44], 3/3 [mean ages 48/48], 5/4 [mean ages 52/52], 7/5 [mean ages 55/55], 9/6 [mean ages 
59/59], 11/7 [mean ages 62/62], were selected where mean age of Original Cohort were 
similar to the mean age of the Offspring Cohort (Table 3.1). Figure 4.1 is a flowchart 
showing participants who were retained and excluded after inclusion criteria was applied. 
Participants who were recorded as “attended” at any given exam cycle was used as the 
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denominator for the exam cycle. 
  
Figure 4. 1  Flowchart showing selection of eligible number participants and those excluded 
from the study after pairing offspring to their parents. 
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Sample Characteristics of Original and Offspring Cohorts  
 At total of 3,492 offspring were paired with 2,734 unique parents (mothers [n=1, 416] 
and/or fathers [n=1,318]) derived from 1,044 distinct families with a mean of 2 children per 
family (minimum 1, maximum 9). Each exam had a different number of offspring and 
parents which represents the participants who attended that exam cycle. Out of the 1, 044 
families, 399 (38.2%) had one child, 347 (33.2%) had 2 children, 183 (17.5%) had 3 
children, 81 (7.8%) had 4 children, 17 (1.6%) had 5 children, 12 (1.2%) had 6 children, 4 
(0.4%) had 7 children and 1 (0.1%) had 9 children.   
 Table 4.1 shows summary demographic characteristics of Original and Offspring 
Cohorts who attended each exam cycle. Gender was equally distributed in either cohort, 
although the proportions of women were slightly higher than men in both cohorts (p<0.001). 
Women were slightly younger than men in Original Cohort (p<0.05) except last exams 9 and 
11. However, no statistically significant differences in mean ages of women and men in 
Offspring Cohort except in older age where women were slightly older than men. Most 
(35.6% parents vs 33.3 offspring) participants were aged 35-44 years at the first eligible 
inclusion exam. In each age group of the Original Cohort, the proportion of mothers aged 55 
years and above was significantly lower than of fathers (p<0.05) except at exams 9 and 11. 
No statistically significant differences noted among age categories for the offspring male and 
female participants (Table 4.3). In Table 4.1, nearly a half (45%) of the Original Cohort 
participants had not completed high school education while more than 93% of the offspring 
participants had attained at least high school education.  Noteworthy among the two cohorts 
was that there was remarkable difference in the proportion of housewives in the Offspring 
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Cohort compared with their parents (20.4% vs 43.4%), with the offspring occupying most of 
the professional jobs.  
Table 4. 1  
Sample characteristics of Original and Offspring Cohorts by sex in each matched exam cycle 
FHS Original Cohort n=2734  FHS Offspring Cohort n=3492 
Characteristic  Total n% Male n% Female n%  
P 
value 
Characteristic  Total n% Male n% Female n%  
P 
value 
Sex 2637(100) 1290(48.9) 1347(51.1) 0.000 Sex  2617(100) 1246(47.6) 1371(52.4) 0.000 
Age (mean/SD) 
  
  
Age 
(mean/SD)     
Exam1 n=2637 43.1 (8.3) 44.3 (8.4) 43.0 (8.2) 0.000 Exam2 n=2617 43.1(10.2) 42.8 (10.3) 43.3 (10.1) 0.147 
Exam3 n=2341 47.4 (8.3) 48.0 (8.3) 47.0 (8.2) 0.002 Exam3 n=2631 47.2(10.2) 46.8 (10.2) 47.2 (10.3) 0.062 
Exam5 n=2365 51.2 (8.3) 51.7 (8.2) 50.8 (8.2) 0.008 Exam4 n=2686 50.3(10.2) 49.9 (10.1) 50.6 (10.2) 0.058 
Exam7 n=2275 55.0 (8.2) 55.3 (8.2) 54.6 (8.1) 0.030 Exam5 n=2555 53.7(10.1) 53.3 (10.1) 54.1 (10.2) 0.049 
Exam9 n=2136 58.7 (8.1) 58.9 (8.1) 58.4 (8.1) 0.127 Exam6 n=2366 57.6(10.0) 57.0 (9.8) 58.1 (10.1) 0.004 
Exam11n=1708 62.0 (7.8) 62.3 (7.8) 61.8 (7.8) 0.182 Exam7 n=2412 60.6 (9.9) 60.0 (9.7) 61.1 (10.0) 0.005 
Marital status (n= 2365) (Exam 5)    Marital status (n=2617) (Exam 2)   
Married 2294(97.0) 1124(99.4) 1170(94.8) 
0.000 
Married 1984(75.8) 1033(79.5) 999 (69.7) 
0.000 
Single 0 (0.0) 1 (0.08) 6 (0.7) Single 319 (12.2) 134 (10.3) 159 (11.1) 
Widowed 53 (2.2) 4 (0.4) 49 (4.0) Widowed 61 (2.3) 16 (1.2) 101 (7.1) 
Divorced/ 
Separated 
17 (0.89) 3 (0.3) 14 (1.1) 
Divorced/ 
Separated 
253 (9.7) 94 (7.2) 152 (10.6) 
Education level (n=2543) (Exam 1-7)    Education level (n=2611) (Exam 2)   
 <High school 1132(44.5) 585 (47.3) 547 (41.9) 
0.000 
 <High school 172 (6.6) 87 (7.0) 85 (6.2) 
0.000 
High school 730 (28.7) 307 (24.8) 423 (32.4) High school 875 (33.5) 368 (29.6) 507 (37.0) 
Some college 204 (8.0) 99 (8.0) 105 (8.0) Some college 725 (27.8) 292 (23.5) 433 (31.6) 
≥College grad 477 (18.8) 246 (19.9) 231 (17.7) ≥College grad 839 (32.3) 495 (39.9) 344 (25.1) 
Type of work (n=2208) (Exam 6)    Type of work (n=2506) (Exam 2)   
Professional 122 5.5) 104 (10.0) 18 (1.5) 
0.000 
Professional 486 (19.4) 267 (22.6) 219 (16.5) 
0.000 
Executive  21 (1.0) 21 (2.0) 0 (0.0) Executive  27 (1.1) 23 (2.0) 4 (0.3) 
Supervisory 292 (13.2) 273 (26.4) 19 (1.6) Supervisory 188 (7.5) 152 (12.9) 36 (2.7) 
Technical 130 (5.9) 124 (12.0) 6 (0.5) Technical 175 (7.0) 124 (10.5) 51 (3.9) 
Laborer 521 (23.6) 400 (38.6) 121 (10.3) Laborer 594 (23.7) 468 (39.6) 126 (9.5) 
Clerical 74 (3.4) 37 (3.5) 37 (3.2) Clerical 401(16.0) 42 (3.6) 359 (27.1) 
Sales 89 (4.0) 77 (7.4) 12 (1.0) Sales 125 (5.0) 103 (8.7) 22 (1.7) 
Housewife 959 (43.4) 0 (0.0) 959 (81.8)   Housewife 510 (20.4) 0 (0.0) 510 (38.5)   
Note: Sample size in each exam include only eligible participants that attended the specific exam; eligible participants are unique 
individuals in each cohort 
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Comparison of Body Mass Index for Original versus Offspring Cohorts 
 All descriptive tables present eligible participants’ iCVH metrics for unique 
individual Original and Offspring participants. Note that according to the iCVH classification 
“ideal” metric is the most desirable and “poor” is undesirable cardiovascular health status. In 
all the seven iCVH metrics, “poor”, “intermediate” and “ideal” metrics are coded as 0, 1 and 
2 respectively. Table 4.2 presents descriptive statistics for BMI by Cohort at each exam 
categorized using iCVH classification criteria (Table 4.2). Two-sample t-test comparing 
mean BMI showed the Offspring Cohort had a significantly higher mean BMI in most of the 
paired exam cycles compared with Original Cohort (p<0.05) except at younger ages. Overall 
BMI trend for all exam cycles showed that the Offspring Cohort had a higher proportion of 
“poor” BMI status compared with the Original Cohort. 
Table 4. 2 Original and Offspring Cohorts body mass index metric by ideal cardiovascular 
health classification 
Exam # Mean/SD Poor Intermediate Ideal Exam # Mean/SD Poor Intermediate Ideal P value
Exam 1
 n=2634 25.8 (4.2) 371 (14.1) 1056 (40.1) 1207 (45.8)
Exam 2
 n=2616 25.6 (4.5) 380 (14.5) 926 (35.4) 1310 (50.1) 0.217
Exam 3
 n=2338     26.0 (4.0) 302 (13.0) 1043 (44.6)  993 (42.5)
Exam 3
n=2582  25.8 (4.6) 464 (18.0) 1022 (39.6) 1096 (42.5) 0.204
Exam 5
 n=2356      26.0 (4.0) 323 (13.7) 1016 (43.1) 1017 (43.2)
Exam 4 
n=2672 26.4 (4.8)  568 (21.3) 1091 (40.8) 1013 (37.9) 0.000
Exam 7
 n=2210      26.1 (4.0) 312 (14.1 959 (43.4) 939 (42.5)
Exam 5 
n=2534 26.9 (4.9) 622 (24.6) 1050 (41.4)  862 (34.0) 0.000
Exam 9 
n=2070     26.1 (4.0) 289 (14.0) 901 (43.5) 880 (42.5)
Exam 6
 n=2331 27.5 (4.9)  684 (29.3) 984 (42.2) 663 (28.4) 0.000
Exam11
n=1683     26.5 (4.1) 272 (16.2) 767 (45.6) 644 (38.3)
Exam 7 
n=2281  27.9 (5.2) 711 (31.2) 953 (41.8) 617 (27.1) 0.000
 FHS Original (Parents) Cohort  FHS Offspring Cohort  
BMI classification: Poor; ≥30, Intermediate; 25-29.9, Ideal;<25; p values calculated from ttest for mean parent-offspring BMI  
Comparison of Blood Pressure for Original versus Offspring Cohorts 
 Table 4.3 presents descriptive statistics for blood pressure by Cohort at each cycle. 
Blood pressure was derived as shown in Table 4.3 from systolic blood pressure (SBP) and 
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diastolic blood pressure (DBP). Blood pressure measurements for parents compared with 
offspring were statistically different in all matched exam cycles (p<0.05). Parents had higher 
proportion of high blood pressure at each exam cycle. For instance, parents with poor blood 
pressure (SBP≥140 or DBP≥90mmHg) compared with offspring in paired exams 1 versus 2 
and exams 11 versus 7 was 37.9% vs. 17.6% (p<0.001) and parents in exam 11 versus 
offspring exam 7 was 45.9% vs. 22.3% (p<0.001) respectively. 
Table 4. 3  
Original and Offspring Cohorts blood pressure metric by ideal cardiovascular health 
classification 
 FHS Original (Parents) Cohort   FHS Offspring Cohort     
Exam # Poor Intermediate Ideal Exam # Poor Intermediate Ideal 
P 
value 
Exam 1  
n=2637   998 (37.9) 1101 (41.8) 538(20.4) 
Exam 2  
n=2617  460 (17.6) 971 (37.1) 1186 (45.3) 0.000 
Exam 3 
n=2341 662 (28.3) 917 (39.2) 762(32.6) 
Exam 3  
n=2631 532 (20.2) 1021 (38.8) 1078 (41.0) 0.000 
Exam 5  
n=2365 841 (35.6) 907 (38.4) 617(26.1) 
Exam 4  
n=2686 656 (24.4) 1061 (39.5) 969 (36.1) 0.000 
Exam 7  
n=2275 1030(45.3) 854 (37.5) 391(17.2) 
Exam 5  
n=2555 502 (19.7) 1013 (39.7) 1040 (40.7) 0.000 
Exam 9  
n=2136 980 (45.9 798 (37.4) 358(16.8) 
Exam 6  
n=2365 527 (22.3) 963 (40.7) 875 (37.0) 0.000 
Exam11 
n=1696 887 (52.3) 597 (35.2) 212(12.5) 
Exam 7  
n=2408 580 (24.1) 984 (40.9) 844 (35.1) 0.000 
Ideal blood pressure Poor: SBP≥140 or DBP≥90mmHg; Intermediate=SBP 120–139/DBP 80–89 mmHg; 
Ideal:<120/<80mmHg; P values computed from χ2 test for blood pressure categories of parents and offspring 
Comparison of Smoking Patterns for Original versus Offspring Cohorts  
 Table 4.4 presents descriptive statistics of cigarette smoking between the two cohorts. 
A higher proportion of parents were “current” (“poor” category) smokers compared with 
their offspring at similar mean age in all exams (p<0.001) and consequently offspring had 
higher attainment of ideal smoking status (no smoking). For instance, 58.5% (n=1533) of the 
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parents at exam 1 had “poor” category smoking status, compared with the corresponding 
39.5% (n=1033) offspring (p<0.001) and the gap continue to widen with age. 
Table 4. 4 Original and Offspring Cohorts smoking status by ideal cardiovascular health 
classification 
 FHS Original (Parents) Cohort   FHS Offspring Cohort     
Exam # Poor Intermediate Ideal Exam # Poor Intermediate Ideal 
P 
value 
Exam 1 
n=2619 1533 (58.5) 166 (6.3) 920 (35.1) 
Exam 2 
n=2617 1033 (39.5) 63 (2.4) 1521 (58.1) 0.000 
Exam 3   
n=2216 1216 (54.9) 40 (1.8) 960 (43.3) 
Exam 3 
n=2628  789 (30.2) 07 (0.3) 1832 (69.7) 0.000 
Exam 5   
n= 2361 1293 (54.8) 286 (12.1) 782 (33.1) 
Exam 4 
n=2679  670 (25.0) 13 (0.5) 1996 (74.5) 0.000 
Exam 7   
n=2233 1134 (50.8) 4 (0.2) 1095 (49.0) 
Exam 5 
n=2552  495 (19.4) 35 (1.4) 2022 (79.2) 0.000 
Exam 9   
n=2136 839 (39.3) 177 (8.3) 1120 (52.4) 
Exam 6 
n=2358 339 (14.4) 36 (1.5) 1983 (84.1) 0.000 
Exam11  
n=1018 610 (36.1) 61 (3.6) 1018 (60.3) 
Exam 7 
n=2408  317 (13.2) 21 (0.9) 2070 (86.0) 0.000 
Smoking categories, Poor: current smoker; Intermediate: former ≤12 months; Ideal: Never/quit >12 months; P value 
computed from Chi-square of cigarette smoking categories for parents and offspring 
Comparison of Blood Glucose Patterns for Original versus Offspring Cohorts 
 Table 4.5 presents descriptive statistics for blood glucose metric by cohort for 
offspring matched to their parents at each exam period. Blood glucose was measured using 
random blood glucose (RBG) for the Offspring Cohort while fasting blood glucose (FBG) for 
the Offspring Cohort. Therefore, the mean/SD for blood glucose may not be comparable 
since different test units were used but the iCVH categorization (poor, intermediate, ideal) is 
comparable as it takes into consideration the respective FBG or RBG categorizations. 
Offspring Cohort have higher proportion of abnormal/high blood glucose (poor blood 
glucose score) compared to their parents in all exam periods (p<0.01), consequently, 
offspring had a higher prevalence of diabetes than their parents. 
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Table 4. 5  
Original and Offspring Cohorts blood glucose metric by ideal cardiovascular health 
classification 
Exam # Mean/SD Poor n%
Intermedi
ate n% Ideal n% Exam # Mean/SD Poor n%
Intermedi
ate n% Ideal n% P value
Exam 1
n=2576 82.0 (22.6) 18 (0.7) 19 (0.7) 2539 (98.6)
Exam  2 
n=2509 98.6 (18.5) 84 (3.4) 840 (33.5) 1585 (63.2) 0.000
Exam 3
n=2304    83.1 (21.8) 19 (0.8) 18 (0.8) 2267 (98.4)
Exam  3 
n=2437 94.1 (22.3) 80 (3.3) 403 ( 16.5) 1954 (80.2) 0.000
Exam 5
n=2240    81.6 (25.1) 19 (0.8) 28 (1.2) 2240 (98.0)
Exam  4 
n=2481 95.6 (26.5) 106 (4.3) 381 (15.4) 1994 (80.4) 0.000
Exam 7
n=2200    81.6 (24.2) 18 (0.8) 26 (1.2) 2156 (98.0)
Exam  5 
n=2489 100.2 (26.8) 149 (6.0) 666 (26.8) 1674 (67.3) 0.000
Exam 9  
n=2095    86.6 (29.6) 29 (1.4) 46 (2.2) 2020 (96.4)
Exam  6 
n=2275 103.3 (27.3) 183 (8.0) 765 (33.6) 1327 (58.3) 0.000
Exam11
n=1673   117.3 (45.3) 85 (5.1) 309 (18.5) 1279 (76.5)
Exam  7 
n=2228 103.7 (26.1) 195 (8.8) 773 (34.7) 1260 (56.6) 0.000
 FHS Original (Parents) Cohort  FHS Offspring Cohort  
Original Cohort:Random Blood Glucose Poor= ≥ 200 mg/dL, Intermediate=140-199 mg/dL, Ideal= <140 mg/dL; 
Offspring: Fasting Blood Gluose: Poor= ≥ 126 mg/dL, Intermediate=100-125 mg/dL, Ideal= <100 mg/dL; p values 
computed from χ2 comparing blood glucose categories for parents and offspring
 
Comparison of Blood Cholesterol Trends for Original versus Offspring Cohorts 
 Table 4.6 presents descriptive statistics for non-fasting total blood cholesterol by 
cohort for offspring matched to biological parents for each exam period. Total blood 
cholesterol (“poor” category score ≥240 mg/dl) was significantly higher for parents 
compared with their offspring in all observation exam periods. At exam 5 for example, 
47.3% (n=1104) of the parents had poor cholesterol score compared with 19.2% (n=502) in 
the matched offspring exam 4 (p<0.001). In other words, a higher proportion of offspring 
achieved ideal cholesterol score compared with their parents in all matched exam cycles. 
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Table 4. 6  
Comparing Original and Offspring Cohorts total cholesterol trends by ideal cardiovascular 
health classification 
Exam # Mean/SD Poor n%
Intermedi
ate n% Ideal n% Exam # Mean/SD Poor n%
Intermedi
ate n% Ideal n% P value
Exam 1  
n=2567     224.6 (45.1) 852 (33.2) 885 (34.5) 830 (32.3)
Exam 2
 n=2612 200.6 (38.8) 380 (14.6) 828 (31.7) 1404 (53.8) 0.000
Exam 3 
 n= 2311    230.2 (44.5) 894(38.7) 860 (37.2) 557 (24.1)
Exam 3 
n=2542 209.6 (41.5) 552 (21.7) 895 (35.2) 1095 (43.1) 0.000
Exam 5  
n= 2336   241.1 (45.2) 1104 (47.3) 834 (35.7) 398 (17.0)
Exam 4 
n=2615 207.3 (39.8) 502 (19.2) 959 (36.7) 1154 (44.1) 0.000
Exam 7 
 n= 2251    252.3 (50.5) 1293 (57.4) 720 (32.0) 238 (10.6)
Exam  5 
n=2535 203.9 (36.8) 402 (15.9) 937 (37.0) 1196 (47.2) 0.000
Exam 9  
n= 2118     242.2 (46.1) 1019 (48.1) 774 (36.5) 325 (15.3)
Exam 6
 n=2332 207.0 (40.6) 438 (18.8) 839 (36.0) 1055 (45.2) 0.000
Exam11 
n= 1673 233.8 (42.6) 697 (41.7) 631 (37.7) 345 (20.6)
Exam 7 
n=2279 200.2 (37.1) 320 (14.0) 757 (33.2) 1202 (52.7) 0.000
 FHS Original (Parents) Cohort  FHS Offspring Cohort  
Total blood cholesterol poor=>=240; intermediate=200-239; ideal= <200 mg/dl; p values signifant α<0.05 for both ttest for 
means and χ2 for categorical cholesterol for parents and offspring  
Comparison of Physical Activity Trends for Original versus Offspring Cohorts 
 Table 4.7 presents descriptive statistics for physical activity for offspring and their 
parents for each exam period. However, physical activity data for iCVH classification was 
only available in only two exams for each cohort (exams 4 & 11 for Original Cohort and 
exams 2 &4 for Offspring Cohort). Most of the offspring (>50%) attained higher levels of 
ideal physical activity compared with their parents (<40%). Physical activity score was 
collapsed into three categories less than 30 representing “poor” category, 30-33 for 
“intermediate” category and greater than 33 for “ideal” category physical activity levels as 
described in the methods section. Notably, physical activity in the FHS data was recorded as 
duration in number of hours spent doing a particular task per day.  
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Table 4. 7 
 Original and Offspring Cohorts physical activity metric by ideal cardiovascular health 
classification 
 FHS Original (Parents) Cohort   FHS Offspring Cohort   
Exam # Poor Intermediate Ideal Exam # Poor Intermediate Ideal 
Exam 4   
n=2147  632 (29.4)  903 (42.1) 612 (28.5) 
Exam 2 
n=2614 422 (16.1) 886 (33.9) 1306 (50.0) 
Exam11 
n= 395 327 (82.8) 34 (8.6) 33 (8.6) 
Exam 4 
n=2587  289 (11.2) 511 (19.8) 1787 (69.0) 
Physical activity categorized using physical activity score <30=poor; 30-33= intermediate; >33= ideal, 
calculated using the formula: Physical activity score= (1.0 x hrsleep) + (1.1 x hrsedentary) + (1.5 x hrslight) + 
(2.4 x hrmoderate) + (5.0 x hrheavy). Adapted from "Estimating the effect of long-term physical activity on 
cardiovascular disease and mortality: evidence from the Framingham Heart Study" by Shortreed, Peeters, 
& Forbes, 2013, Heart (British Cardiac Society), 99(9), 649–654. https://doi.org/10.1136/heartjnl-2012-
303461 and "Factors of risk in the development of coronary heart disease--six-year follow-up experience. 
The Framingham Study" by Kannel, Dawber, Kagan, Revotskie, & Stokes, 1961, Annals of Internal 
Medicine, 55, 33–50. 
Comparison of five food components for Original versus Offspring Cohorts 
 Table 4.8 presents descriptive statistics for dietary components by Cohort for 
offspring (exams 3, 5, 6, 7) and parents (exam 20, 21, 22). Data in Table 4.8 was used to 
calculate the ideal diet score in Table 4.9. Achievement of recommended servings of food 
categories was low for both Original Cohort and Offspring Cohort, overall less than 25% 
achievement of recommended levels of any of the five food groups, with the lowest 
attainment for fruits and vegetable intake. Offspring had an overall poor dietary pattern with 
the lowest proportions of recommended servings of all the five food groups. 
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Table 4. 8  
Five food categories for computing ideal diet metrics as recommended by the American 
Heart Association (AHA) 
FHS Original (parents) cohort (n%)  FHS Offspring Cohort (n%) 
1. Fruits & vegetables-servings/day (recommended ≥4 servings/day) 
Exam 
<4 
servings/day 
 (n%) 
≥4 
servings/day 
(n%) Exam 
<4 
servings/day 
(n%) 
≥4 
servings/day 
(n%) 
Exam 20 n=548   543 (99.1)  5 (0.9) Exam 3 n=2530 2,517 (99.5)  13 (0.5)  
Exam 21 n=418  409 (97.9)   6 (2.2) Exam 5 n=2298 2,286 (99.5) 12 (0.5) 
Exam 22 n=342  341 (99.7)  1 (0.3) Exam 6 n=2104  2,095 (99.6)  9 (0.4) 
      Exam 7 n=2076 2,064 (99.4)   12 (0.6)  
2. Whole grains servings/day (recommended ≥6 servings/day) 
  
<6 
servings/day 
 ≥6 
servings/day   
<6 
servings/day 
 ≥6 
servings/day 
Exam 20 n=548 536 (97.8)  12 (2.2) Exam 3 n=2531 2,427 (95.9) 104 (4.1) 
Exam 21 n=418  407 (97.4)   11 (2.7) Exam 5 n=2298 2,243 (97.6) 55 (2.4) 
Exam 22 n=342  333 (97.4)  9 (2.6) Exam 6 n=2104 2,079 (98.8)  25 (1.2) 
      Exam 7 n=2076 2,050 (98.8) 26 (1.3) 
3. Nuts/Legumes-servings/week (recommended ≥4 servings/week) 
  
<4 
servings/wk 
 ≥4 
servings/wk   
<4 
servings/wk 
 ≥4 
servings/wk 
Exam 20 n=548 526 (96.0)  22 (4.0) Exam 3 n=2527 2,136 (84.5)  391 (15.5) 
Exam 21 n=418  404 (96.7)  14 (3.4) Exam 5 n=2298 1,848 (80.4)  450 (19.6) 
Exam 22 n=342 323 (94.4)  19 (5.6) Exam 6 n=2104 2,079 (98.8) 25 (1.2) 
      Exam 7 n=2076 2,050 (98.8) 26 (1.3) 
4. Meat/Poultry-servings/week (recommended ≤9 servings/wk) 
  
>9 
servings/wk 
 ≤9 
servings/wk   
>9 
servings/wk 
 ≤9 
servings/wk 
Exam 20 n=548 121 (22.1)  427 (77.9)  Exam 3 n=2536 2,395 (94.4) 141 (5.6) 
Exam 21 n=418  213 (51.0)  205 (49.0) Exam 5 n=2298 2,202 (95.8) 96 (4.2) 
Exam 22 n=342 165 (48.2) 177 (51.8) Exam 6 n=2104 1,889 (89.8)  215 (10.2) 
      Exam 7 n=2076 1,821 (87.7) 255 (12.3) 
5. Low fats/milk-servings/day (recommended ≤3 servings/day) 
  
 >3 
servings/day 
 ≤3 
servings/wk   
 >3 
servings/day 
 ≤3 
servings/wk 
Exam 20 n=548 404 (73.7)  144 (26.3) Exam 3 n=2596 2,246 (88.8) 283 (11.2) 
Exam 21 n=418   317 (75.8) 101 (24.2) Exam 5 n=2297 2,012 (87.6) 285 (12.4) 
Exam 22 n=342  278 (81.3) 64 (18.7) Exam 6 n=2103 1,810 (86.1) 293 (13.9) 
      Exam 7 n=2076 1,804 (86.9) 272 (13.1) 
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Ideal Diet for Original versus Offspring Cohorts  
 Table 4.9 shows that offspring had a lower attainment of recommended dietary 
requirements than the parents. No test of statistical significance was done since the available 
dietary data for Original and Offspring Cohorts were derived from exams where parents-
offspring were not similar by mean age as with other phenotypes in this study. Most of the 
Offspring Cohort had high proportion of poor dietary scores ranging from 80.4% to 99.5% 
across exam periods. Ideal diet score was defined using the number of achieved dietary 
components as shown in Table 4.9. Of note, no parent in Original Cohort achieved ideal” diet 
category or attained 4-5 dietary components. This pattern was similar to that for Offspring, 
except for just one offspring achieved an “ideal” diet category at exam 5 cycle. 
Table 4. 9 
 Ideal diet score for Original and Offspring Cohorts by ideal cardiovascular health 
classification 
 FHS Original (Parents) Cohort   FHS Offspring Cohort   
Exam # Poor Intermediate Ideal Exam # Poor Intermediate Ideal 
Exam 20   
n=548 416 (75.9) 132 (24.1) 0 (0.0) 
Exam 3 
n=2517 2389 (94.9) 128 (5.1)  0 (0.0) 
Exam 21   
n=418 361 (86.4) 57 (13.6) 0 (0.0) 
Exam 5 
n=2297 1948 (84.8)  348 (15.2) 1 (0.04) 
Exam 2 
n=342 296 (86.6 46 (13.5) 0 (0.0) 
Exam 6 
n=2103 1949 (92.7) 154 (7.3) 0 (0.0) 
     
Exam 7 
n=2076 1894 (91.2) 182 (8.8) 0 (0.0) 
Ideal diet score   poor=0-1 components, intermediate=2-3 components, ideal=4-5 components; Dietary 
components include: 1. diet-fruits/veg, 2. whole grains, 3. nuts/legumes, 4. unsaturated fat/milk, 5. lean meat  
Comparison of iCVH trends for Original versus Offspring Cohorts 
 Table 4.10 presents descriptive statistics for an aggregate of all the seven iCVH 
metrics (BMI, blood pressure, smoking, blood sugar, cholesterol, physical activity and diet) 
calculated using data from Tables 4.2-4.9 and stratified by cohorts whereby for offspring’s 
iCVH scores were matched to the iCVH scores of parents at each exam cycle. The iCVH 
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categories were coded as “poor” =0, “intermediate” =1, “ideal” =2. Note that since not all 
iCVH metrics were available for all exam cycles, iCVH categories were generated in two 
ways: (1) Using five iCVH metrics available in both cohorts (this excludes diet and physical 
activity which were only available for few exams). Maximum iCVH score using 5-iCVH 
metrics classification was 10 (i.e., 2x5) for continuous iCVH variable using five metrics, and 
(2) Using seven iCVH metrics (this includes criteria 1 above plus “ideal” diet and physical 
activity scores at available exams cycles). For uniformity, the available diet and physical 
activity metrics were each averaged to create one composite score applied to all exam cycles 
for each cohort. This means, the same diet and physical activity score was used for all the 
exam cycles in the respective cohorts. Maximum iCVH score for this classification was 14 
(i.e 2x7) for continuous iCVH variable using seven metrics. 
 As shown in Table 4.10, none of the cohort attained an “ideal” iCVH score of all 
seven metrics (iCVH  7 metrics). However, few participants in both Cohorts (<5%) achieved 
least five iCVH metrics. No statistically significant difference was noted for achieving 7 
iCVH metrics for parents and offspring in all included exams (p>0.05 at all exams cycles). 
However, the Offspring Cohort had a higher mean iCVH metrics at all exam cycle for both 5 
and 7 metrics. In addition, parents had a higher trend of having poor iCVH metrics (for both 
5 or 7 iCVH metrics) compared to offspring. The mean iCVH scores for offspring (range 6.6-
6.8) were slightly higher than the parents (range 5.6-6.1) at all the paired exam cycles. 
Notably, mean iCVH score remained fairly constant throughout for both cohorts. No 
statistically significant differences between parents’ and offspring’s iCVH in four out of six 
exam cycles using the 7-metric criteria (p>0.05) were observed. 
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Table 4. 10  
Original and Offspring ideal cardiovascular health score by ideal cardiovascular health 
classification 
Exam 1  
Mean/SD
Poor     
(n%)
Intermediate 
(n%)
Ideal 
(n%)
Exam 2
Mean/SD
Poor     
(n%)
Intermediate 
(n%)
Ideal 
(n%) P value
5metrics 
n=2540     5.9 (1.7) 556 (21.9) 1930 (78.9) 54 (2.1)
n=2501
6.7 (2.0) 367 (14.6) 1909 (76.2) 231 (9.2) 0.000
7metrics 
n=620    7.8 (2.0) 158 (25.5) 462  (74.5) 0 (0.0)
n=2339
8.4 (2.2) 466 (19.9) 1873 (80.1) 0 (0.0) 0.094
Exam 3 Exam 3
5metrics 
n=2171     6.1 (1.7) 408 (18.8) 1712 (78.9) 51 (2.4)
n=2421 
6.8 (2.0) 328 (13.6) 1849 (76.4) 244 (10.1) 0.000
7metrics 
n=562 7.9 (2.0) 130 (23.1) 432 (76.9) 0 (0.0)
n=2314 
8.4 (2.2) 435 (18.8) 1879 (81.2) 0 (0.0) 0.040
Exam 5 Exam 4
5metrics 
n=2265     5.7 (1.7) 560 (24.7) 1681 (74.2) 24 (1.1)
 n=2466 
6.8 (2.0) 335 (13.6) 1886 (76.5) 245 (9.9) 0.000
7metrics 
n=617  7.4 (2.0) 198 (32.1) 419 (67.9) 0 (0.0)
n=2389  
8.4 (2.2) 466 (19.5) 1923 (80.5) 0 (0.0) 0.020
Exam 7 Exam 5
5metrics 
n=2114      5.5 (1.6) 560 (26.5) 1539 (72.8) 15 (0.7)
n=2476
6.8 (1.9) 277 (11.2) 1987 (80.3) 212 (8.6) 0.000
7metrics 
n=606  7.1 (1.9) 240 (39.6) 366 (60.4) 0 (0.0)
 n=2381
8.4 (2.1) 406 (17.1) 1975 (83.0) 0 (0.0) 0.072
Exam 9 Exam 6
5metrics 
n=2031   5.8 (1.6) 454 (22.4) 1557 (76.7) 20 (1.0)
 n= 2263
6.6 (1.8) 309 (13.7) 1831 (80.9) 123 (5.4) 0.000
7metrics 
n=613  7.2 (1.9) 206 (33.6) 407 (66.4) 0 (0.0)
 n= 2196  
8.2 (2.0) 452 (20.6) 1744 (79.4) 0 (0.0) 0.295
Exam 11 Exam 7
5metrics 
n=1626     5.6 (1.7) 417 (25.7) 1199 (73.7) 10 (0.6)
 n=2220
6.7 (1.8) 251 (11.3) 1833 (82.6) 136 (6.1) 0.000
5metrics 
n=544 7.0 (1.9) 214 (39.3) 330 (760.7) 0 (0.0)
n=2136
8.2 (2.0) 416 (19.5) 1729 (80.5) 0 (0.0) 0.978
 FHS Offspring Cohort  FHS Original (parents) Cohort 
Note: 5 and 7 metrics denote iCVH score computed using 5 and 7 iCVH metrics, namely-BMI, cholesterol, 
blood glucose, blood pressure, smoking, (physical activity and diet); P values computed using χ 2 to test 
differences between parents and offspring iCVH scores  
 
Figures 4.2 and 4.3 below show the proportions of iCVH categories of parents and offspring 
over time using AHA criteria 5-metrics. Neither parents nor offspring attained “ideal” iCVH 
level at any exam cycle. 
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Figure 4. 2. FHS parents’ iCVH metrics over time (1948-1971)  
 
 
 
Figure 4. 3. FHS offspring iCVH metrics over time (1971-2001) 
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Cardiovascular Disease Events and DALYs 
 Cardiovascular disease was defined using the FHS criteria comprising of one or more 
heart or blood vessel conditions including coronary heart disease, intermittent claudication, 
congestive heart failure, stroke or transient ischemic attack (TIA). The date of the first CVD 
event was used as the overall date the individual was diagnosed with CVD regardless of 
multiple future CVD events. The events were recorded were coded using International 
Classification of Diseases, ninth edition (ICD-9). Table 4.11 presents exam-specific 
incidence of CVD events. The table shows that parents had a higher incidence of CVD than 
the offspring except at the third matched exam cycles, p=0.812). Incidence of CVD in 
parents increased more with increasing age-group ranging from 3.5%-16.4% in Original 
Cohort, and from 3.6%-5.3% in offspring. Incidence rate was lowest at exam cycles at which 
Original and Offspring Cohorts were younger particularly at exams when either cohort had a 
mean age younger than 50 years.  
Table 4. 11  
Incidence of cardiovascular disease events for Original and Offspring Cohort at each paired 
exam cycle 
Original Cohort Offspring Cohort   
Exam/Year 
Number at 
risk 
#CVD 
events  Incidence % Exam/Year 
Number 
at risk 
#CVD 
events  Incidence % 
p 
value 
Exam 1 (1948-
1953) 
2637 
219 8.3 
Exam 2 (1979-
1983) 
2617 
101 3.9 0.001 
Exam 3 (1954-
1956)  
2122 
75 3.5 
Exam 3 (1984-
1987) 
2530 
92 3.6 0.812 
Exam 5 (1957-
1960)  
2071 
137 6.6 
Exam 4 (1988-
1991) 
2493 
103 4.1 0.001 
Exam 7 (1961-
1964) 
1844 
157 8.5 
Exam 5 (1991-
1995) 
2259 
107 4.7 0.000 
Exam 9 (1965-
1968) 
1548 
220 14.2 
Exam 6 (1995-
1998) 
1963 
84 4.3 0.000 
Exam11 (1969-
1971) 
900 
148 16.4 
Exam 7 (1998-
2001) 
1925 
102 5.3 0.000 
Total  CVD events 956   Total  CVD events 589     
Note: %Incidence= [Number (#) of CVD events (at each exam)/number of persons at risk]x100.; # at risk=number of eligible 
participants at each exam-#CVD events in previous exams; p value computed from χ2, significant at α<0.05 
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 Table 4.12 shows mean CVD DALYs for the two Cohorts. For comparable exposure 
duration for CVD between cohorts, maximum follow-up period was capped at 43 years 
corresponding to 1948-1991 for the Original Cohort and 1971-2014 for the Offspring Cohort. 
The Offspring Cohort had significantly higher mean CVD DALYs compared to the Original 
Cohort [5.5 (95% CI: 5.2-5.9), vs. 1.8 (95% CI: 1.6-1.9), p<0.001]. With respect to YLLs, 
the Offspring Cohort lost 4.6 years (95% CI: 4.3-5.0) due to early CVD death versus 1.1 
years (95% CI 1.0-3.2) in Original Cohort. To determine the age CVD diagnosis, the 
participant's date of birth was first approximated by subtracting their age (in years) from the 
date of exam cycle 1. This estimation of date of birth was necessary since the real date of 
birth was masked in the FHS database to protect against identification of participants. Age at 
first CVD diagnosis was therefore estimated by subtracting the approximate date of birth 
from the date of first CVD event. This estimation is not perfect, but the best approach given 
the circumstances. The approximated mean age at CVD diagnosis for the Original Cohort 
was 72.5 years (SD=10), which was statistically significantly higher than the mean age at 
CVD diagnosis for the Offspring Cohort of 51.0 years (SD=11.7), p<0.001. The consequence 
of approximating date of birth in the manner described above is that any over-estimation or 
under-estimation CVD diagnosis age were carried forward to the calculation of CVD 
DALYs. The Offspring Cohort had a total of 17,163 CVD DALYs (mean 5.5) compared with 
4, 656 CVD DALYs (mean 1.8) for the Original Cohort. These CVD DALY rates translate to 
550, 273 and 176, 564 per 100,000 population for Offspring and Original Cohorts, 
respectively.  
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Table 4. 12  
Mean CVD YLLs, CVD YLDs, and CVD DALYS for Original and Offspring Cohorts 
  
Original Cohort (Parents) 
  
Offspring Cohort 
    
  n Mean/SE 95% CI N Mean/SE 95% CI 
P 
value 
CVD YLLs 2,637 1.1 (0.06) 0.98-3.24 3,119 4.6 (0.16) 4.30-4.92 0.000 
CVD YLDs 2,637 0.7 (0.03) 0.61-0.96 3,119 0.9 (0.03) 0.82-0.96 0.000 
CVD DALYs 2,637 1.8 (0.07) 1.62-1.91 3,119 5.5 (0.18) 5.15-5.85 0.000 
Total CVD DALYs 
  4, 656      17,163     
YLL= years of life lost; YLD= years lived with disability; DALYs=YLD+ YLL; P value computed using t-test 
for means, significant at α<0.05; CVD DALYs per 100, 000= (total CVDDALYsx100, 000)/n 
Statistical Analysis of Hypothesis 1A 
 Hypothesis 1A postulates that exam cycle-specific iCVH metrics for the two Cohorts 
will be positively linearly correlated. Table 4.13 presents a correlation matrix for iCVH of 
offspring matched to biological parents at each exam cycle. These correlations were 
generated using five iCVH metrics (i.e, excluded physical activity and diet because these 
variables were not available in most exam cycles). The table presents correlation coefficients 
for Offspring with (1) a mean iCVH for parents (mean for mother and/or father), (2) 
correlation coefficient for Offspring with mothers only and (3) correlation coefficient for 
offspring with fathers only. Diagonal correlation coefficients (in bold) represents linear 
associations when both cohorts had similar mean age. Other off-diagonal partial correlation 
coefficients represent non-congruent exam cycles when the parents and offspring are 
mismatched for age distribution. 
 Results of the diagonal Pearson correlations coefficients show that offspring’s iCVH 
was positively linearly correlated with that of their parents at each exam cycle where mean 
age was similar. Correlation coefficients ranged from 0.17-0.25 and declined slightly with 
increasing age-group at all exam cycle pairs. The correlation coefficients were stronger 
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earlier exams when both the Offspring and Original Cohort participants were younger 
ranging from 40-50 years old. Correlation coefficients for iCVH in offspring-mother dyads 
were slightly higher than those of the offspring-father dyads.  
Table 4. 13  
Pearson correlation coefficients matrix for iCVH metrics for Original and Offspring 
matched/mismatched at different exam periods 
  Parents (mother and/or father) 
Offspring iCVH at 
exam 
iCVH exam 1 iCVH exam 3 iCVH exam 5 iCVH exam 7 iCVH exam 9 iCVH exam 11 
iCVH exam 2 n=2029 0.24      
iCVH exam 3 n=2111 0.24 0.25     
iCVH exam 4 n=2269 0.23 0.24 0.23    
iCVH exam 5 n=2197 0.20 0.21 0.20 0.18   
iCVH exam 6 n=1968 0.24 0.23 0.22 0.20 0.21  
iCVH exam 7 n=1669 0.18 0.16 0.17 0.17 0.16 0.17 
  Mothers iCVH 
Offspring iCVH at 
exam 
iCVH exam 1 iCVH exam 3 iCVH exam 5 iCVH exam 7 iCVH exam 9 iCVH exam 11 
iCVH exam 2 n=2037 0.27      
iCVH exam 3 n=1737 0.26 0.28     
iCVH exam 4 n=1800 0.23 0.26 0.25    
iCVH exam 5 n=1736 0.18 0.22 0.20 0.21   
iCVH exam 6 n=1554 0.20 0.21 0.20 0.21 0.20  
iCVH exam 7 n=1319 0.13 0.14 0.14 0.13 0.13 0.17 
  Fathers iCVH 
Offspring iCVH at 
exam 
iCVH exam 1 iCVH exam 3 iCVH exam 5 iCVH exam 7 iCVH exam 9 iCVH exam 11 
iCVH exam 2 n=1945 0.18      
iCVH exam 3 n=1598 0.19 0.17     
iCVH exam 4 n=1715 0.17 0.15 0.16    
iCVH exam 5 n=1625 0.18 0.14 0.16 0.13   
iCVH exam 6 n=1422 0.20 0.16 0.18 0.14 0.13  
iCVH exam 7 n=1123 0.17 0.14 0.16 0.16 0.14 0.13 
Note: sample size for each exam is for paired exam cycles, the outmost diagonal correlations 
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Statistical Analysis for Hypothesis 1B 
  All linear regression analyses were conducted after merging the offspring-parents’ 
dyads. Table 4.14 shows raw and multivariable-adjusted linear regression coefficients (β) at 
each exam cycle. BMI, blood pressure, smoking, blood glucose and total cholesterol were the 
dependent variables. The parents iCVH was the main independent variable. The regression 
coefficient β represents the change in Offspring iCVH for each unit increase in parental 
iCVH. Ideal cardiovascular health, which ranges from 0-10, was modeled as a continuous 
variable. The hypothesis proposed that was parental iCVH would be a positive predictor of 
offspring iCVH. Notably, all the slopes for iCVH for parents paired with their offspring were 
positive and statistically significant at p<0.001 in both raw and multivariable models, 
meaning that an increase in parents iCVH is associated with an increase in the offspring 
iCVH. To put this in perspective using Model 2 regression coefficients/slope (β) for paired 
exams 3 was 0.3 (95% CI=0.18-0.33, p<0.001), meaning that for every 1-unit increase in 
parent iCVH (on a iCVH score of 0-10), offspring iCVH was increased by 0.3 units, 
accounting for age, sex and education level. In the same model (not shown in table), the 
higher the offspring age, the lower the iCVH (β=-0.05, 95% CI= -0.06 to -0.04, p< 0.001), 
female offspring had 15% lower iCVH than male offspring counterpart (p< 0.001), and 
offspring with college education had 31% higher iCVH compared with those with less than a 
college degree. 
 Stratifying offspring iCVH relationships by parents’ gender revealed slightly 
contrasting results in raw and adjusted models. For instance, in Model 1 (unadjusted), 
offspring-mother dyads had a higher iCVH (β=0.31, 95% CI=0.27-0.37, p<0.001) than the 
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offspring-fathers’ dyads (β=0.21, 95% CI=0.16-0.27, p<0.001). However, in Model 2 
(adjusted for age, sex and education), offspring-father had a higher relationship (β=0.18, 95% 
CI=0.13-0.22, p<0.001) than offspring-mother dyads (β=0.17, 95% CI=0.12-0.22, p<0.000). 
Table 4. 14  
Linear regression coefficients showing the relationship between parents iCVH and offspring 
iCVH at each paired exam cycle 
Model 1   Model 2 
Parent/offspring 
exams N Β 95% CI P value n β 95% CI P value 
iCVH exam 1/2   2429 0.34 0.28-0.39 0.000 2423 0.22 0.17-0.27 0.000 
iCVH exam 3/3 2111 0.34 0.27-0.42 0.000 1876 0.26 0.18-0.33 0.000 
iCVH exam 5/4 2269 0.32 0.24-0.39 0.000 1991 0.23 0.16-0.30 0.000 
iCVH exam 7/5 2197 0.25 0.17-0.32 0.000 1917 0.20 0.13-0.27 0.000 
iCVH exam 9/6 1968 0.27 0.21-0.33 0.000 1724 0.23 0.17-0.29 0.000 
iCVH exam 11/7 1669 0.21 0.14-0.27 0.000 1404 0.19 0.12-0.26 0.000 
Note: Model 1, unadjusted; Model 2, adjusted for offspring age, sex, education 
 
 Overall, offspring regression coefficients for iCVH analyzed as a continuous variable 
were largely similar by gender of the parent. The coefficient of determination (R2), i.e., the 
proportion of variability explained by the model explanatory variables was highest in the 
earlier exam cycles (i.e., R2>0.25 when both parents and offspring were younger) indicating 
the strength of parents-offspring’s iCVH strength of relationship is stronger during younger 
age exam cycles. Correlation due to familial clustering was accounted for in all regression 
models. Bootstrapping using multiple repetitions of 50-1000 random samples were used to 
confirm whether there was deviation between estimates with and without accounting for 
familial clustering.  
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Figure 4. 4. Line graph to show trends of iCVH multivariable regression coefficients for 
offspring and parent iCVH across exam cycles 
 Supplemental statistical analysis for aim 1 hypothesis 1B. Additional analysis of 
iCVH as an ordinal variable using AHA criteria “poor” [0], “intermediate” [1] and “ideal” 
[2]). are presented in the next Table 4.15.  Figure 4.4 below shows linear trends of iCVH for 
the relationship of parents and Offspring. Proportional odds model, also known as cumulative 
logit model for ordered logistic regression was used to assess the relationship between 
offspring and parents iCVH. Prior to statistical analysis, the proportional odds assumption 
that the slopes for each outcome across  each level of response variable are  similar was 
assessed (Hedeker, 2015). The Brant test of parallel regression assumption was not 
statistically significant (i.e., paired exam 2-1, p= 0.732) providing evidence that the 
assumption of proportional odds model was not violated (Williams, 2018). Analysis was 
conducted similar to that for hypothesis 1B where Model 1 was not adjusted for confounding, 
but Model 2 was adjusted for offspring demographic characteristics, age, sex, educational 
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level attained. To account for correlation due to familial clustering, regression models were 
run using the ‘cluster’ option in STATA with Family ID as the cluster variable. 
 Table 4.15 presents proportion odds model results examining the relationships 
between ordinal offspring and parents’ iCVH coded in three levels of “poor” (score of≤4) 
“intermediate” (score of 4-9), and “ideal” (score of ≥10) using a mathematical 
formula 𝐏(𝐘 ≥ 𝐣|𝑿𝟏) =
1
1+exp [−(𝜶𝒋 +𝜷𝟏 𝑿𝟏)]
 (Kleinbaum & Klein, 2010), where 
P(Y≥j|X1) is probability of ordinal outcome (Y) with j levels (0,1,2) and independent 
variables (X1). See substituted model 𝑷(𝒐𝒇𝒇𝒊𝑪𝑽𝑯 =
1
1+exp [−(𝜶𝒐,𝟏,𝟐 +𝜷𝟏𝐏𝐢𝐂𝐕𝐇+𝜷𝒊 𝒐𝒇𝒇 (𝒂𝒈𝒆,𝒔𝒆𝒙,𝒆𝒅𝒖𝒄)]
 
Note that only iCVH with five metrics (BMI, blood sugar, blood pressure, blood cholesterol 
and smoking) was considered for this analysis (as explained previously) and excluded 
physical activity and diet variables since they were not available for all exam periods. 
Table 4. 15  
Proportional odds model for relationship of parents and offspring 5-metric iCVH by AHA 
classification 
Model 1   Model 2 
Parent/offspring 
exams N 
Odds 
R 95% CI 
P 
value n 
Odds 
R 95% CI 
P 
value 
iCVH exam 1/2   
2429 
Ref (poor iCVH)   
2423 
      
Intermediate 1.65 1.33-2.03 0.000* 1.63 1.31-2.01 0.000* 
Ideal 5.61 3.18-9.90 0.000* 3.51 1.91-6.45 0.000* 
iCVH exam 3/3  
2111 
Ref (poor iCVH)   
1876 
      
Intermediate 1.75 1.38-2.23 0.000* 1.71 1.31-2.22 0.000* 
Ideal 3.65 2.00-6.68 0.000* 2.12 1.10-4.36 0.026* 
iCVH exam 5/4  
2269 
Ref (poor iCVH)   
1991 
   
Intermediate 1.83 1.45-2.32 0.000* 1.85 1.45-2.36 0.000* 
Ideal 1.50 0.65-3.44 0.343 0.63 0.25-1.58 0.325 
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iCVH exam 7/5 
2197 
Ref (poor iCVH)   
1917 
   
Intermediate 1.57 1.23-2.01 0.000* 1.75 1.36-2.26 0.000* 
Ideal 6.93 
2.81-
17.08 0.000* 3.57 
1.25-
10.26 0.018* 
iCVH exam 9/6   
1968 
Ref (poor iCVH)   
1724 
   
Intermediate 1.90 1.46-2.48 0.000* 2.16 1.61-2.89 0.000* 
Ideal 5.44 
2.46-
12.03 0.000* 2.50 1.20-5.23 0.015* 
iCVH exam 11/7  
1669 
Ref (poor iCVH)   
1453 
   
Intermediate 1.63 1.23-2.15 0.001* 1.61 1.20-2.17 0.002* 
Ideal 4.30 
1.63-
11.37 0.003* 4.34 
1.46-
12.94 0.008* 
Note: Model 1, unadjusted; Model 2, adjusted for offspring age, sex, education, 5-metric 
iCVH used to run models; *p values significant at p<0.05 
 
 Table 4.15 above shows proportional odds ratios for ordered categorical iCVH for 
offspring (dependent variable with ‘poor’ iCVH as the referent category) and parents 
matched by exam cycle. The odds ratio results consistently show the increased likelihood of 
offspring achieving higher iCVH (“intermediate” or “ideal”) when the parents have similar 
level of iCVH levels. The odds of offspring of parents with ideal iCVH attaining ideal iCVH 
is two-to-fourfold accounting for age, sex and education. In Table 4.15 in matched parents’ 
exam cycle 1 and offspring exam cycle 2: among offspring of parents with ideal iCVH, the 
odds of offspring having ideal iCVH was 3.51 times higher compared with offspring of 
parents with “poor” iCVH, after adjusting for age, sex and education. In other words, the 
higher the parental iCVH metric, the higher the odds of offspring achieving a higher iCVH 
across different exam periods in the lifespan. The odds ratios reveal a notable pattern that 
ideal parental iCVH contributes higher offspring iCVH than intermediate iCVH. 
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Statistical Analysis of Hypothesis 2A 
 It was hypothesized that iCVH metrics were important predictors of CVD DALYs. 
Model 1 and Model 2 were fitted at each exam cycle, where Model 1 was comprised of a 
simple regression regressing CVD DALYs with iCVH coded as a continuous predictor.  
Model 2 expanded Model 1 to additionally adjust for age, education, sex and income [see 
Tables 4.16 & 4.17].  
 Table 4.16 show that for the parents, DALYs and iCVH were inversely associated. 
For every one-unit increase in iCVH, there was a reduction in CVD DALYs. For instance, at 
exam cycle 1, CVD DALYs decreased by at least 0.4 years for every one unit increase in 
iCVH adjusted for age, sex and education. The analysis revealed a stronger inverse 
association between iCVH and CVD DALYs at earlier exam cycles when the parent 
participants were younger in age than later exam cycles. At exam cycles 1 and 11, β 
coefficients were larger at exam cycle 1, β (SE)=0.4(SE=0.04) p<0.001; vs. 0.2(SE=0.04) 
years, p<0.001, corresponding to a 50% reduction in the regression slope. Notably, both raw 
and multivariable models for parents iCVH β coefficients were statistically significant 
(p<0.001) in all exam cycles. 
Table 4. 16  
Linear regression coefficients for the relationship between iCVH and CVD DALYS for Original Cohort 
Model 1   Model 2 
Parent exam n β SE P value n β SE P value 
iCVH exam 1   2540 -0.36 0.04 0.000 2478 -0.44 0.04 0.000 
iCVH exam 3  2171 -0.35 0.04 0.000 2121 -0.44 0.04 0.000 
iCVH exam 5  2265 -0.27 0.04 0.000 2203 -0.33 0.04 0.000 
iCVH exam 7  2114 -0.21 0.04 0.000 2060 -0.25 0.04 0.000 
iCVH exam 9  2031 -0.22 0.04 0.000 1978 -0.24 0.04 0.000 
iCVH exam11  1626 -0.15 0.04 0.000 1579 -0.16 0.04 0.000 
Note: Model 1, unadjusted; Model 2, adjusted for parents age, sex, education 
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 Table 4.17 results show even more robust iCVH slopes for offspring compared with 
the slopes for the parents in Table 4.16 above. As a predictor for DALYs in offspring exam 
cycle 1, for every one-unit increase in iCVH, DALYS decreased by 1.2 (SE=0.11), p <0.001 
while accounting for age, sex and education. More robust slopes were observed in earlier 
exam cycles than latter cycles. All β-coefficients for multivariable models for offspring were 
statistically significant (p<0.001). Offspring iCVH, age and sex were significant predictors 
for CVD DALYs (p<0.05) in all exam cycles.  
Table 4. 17  
Linear regression coefficients for the association of iCVH and CVD DALYS among Offspring 
Cohort 
Model 1   Model 2 
Offspring exam N β   P value n β SE P value 
iCVH exam 2  2507 -1.40 0.09 0.000 2501 -1.23 0.11 0.000 
iCVH exam 3  2421 -1.34 0.09 0.000 2146 -1.23 0.11 0.000 
iCVH exam 4 2466 -1.34 0.09 0.000 2159 -1.20 0.11 0.000 
iCVH exam 5  2476 -1.18 0.09 0.000 2150 -1.09 0.10 0.000 
iCVH exam 6 2263 -1.12 0.10 0.000 1983 -1.08 0.11 0.000 
iCVH exam 7  2220 -0.84 0.10 0.003 1932 -0.72 0.11 0.000 
Note: Model 1, unadjusted; Model 2, adjusted for offspring age, sex, education  
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Figure 4. 5. Multivariable-adjusted linear regression coefficients comparing relationship of 
iCVH and CVD DALYs for parents and offspring participants 
Note: Dependent variable, CVD DALYs; independent variable, iCVH; other covariates age, 
sex, education for each cohort  
 
Figure 4.5 comparing β-coefficients for multivariable models show a similar pattern of iCVH 
relationship with CVD DALYs for parents and offspring, with a higher reduction in CVD 
DALYs observed among the offspring. Further analysis using categorical iCVH variables 
showed that those with ideal iCVH had higher reduction in CVD DALYs than those with 
intermediate iCVH. For instance, a multivariable adjusted linear regression model in 
offspring’s exam 2, having ideal iCVH was associated with a reduction in CVD DALYs by 5 
years (95% CI -6.92 to -3.09) compared with 2 years (95% CI -3.80 to-1.4) associated with 
intermediate iCVH, p<0.001. 
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Statistical Analysis of Hypothesis 2B 
 A t-test was used to examine whether offspring of parents with low iCVH will have 
higher mean CVD DALYs compared to the mean CVD DALYs for offspring of parents with 
high iCVH. Table 4.18 below presents mean differences of CVD DALYs for offspring of 
parents with high and low iCVH. The 10-point iCVH for parents was transformed into a 
binary classification, i.e high iCVH (≥6 scores) versus low iCVH (≤5 scores). The null 
hypothesis was rejected since there was a statistically significant relationship between mean 
CVD DALYs of offspring of parents with high iCVH versus mean CVD DALYs of offspring 
of parents with low iCVH in two exams (exam 2 and 4). Offspring of parents with high 
iCVH had lower mean CVD DALYs compared with offspring of parents with low iCVH. 
Even where there was no statistical significance, offspring of parents with low iCVH had 
higher CVD DALYs compared with offspring of parents with high iCVH.  
Table 4. 18  
Mean CVDDALYS for offspring of parents with high versus low iCVH 
Offspring of Parents with 
Low vs High iCVH Offpsring (n) Mean (SE) DALYS 95% CI p value 
Exam 2 
Low iCVH 1426 6.1 (0.3) 5.5-6.6 
0.001* High iCVH 1111 4.7 (0.3) 4.2-5.3 
Exam 3 
Low iCVH 1190 5.8 (0.3) 5.2-6.4 
0.078 
High iCVH 1101 5.1 (0.3) 4.5-5.7 
Exam 4 
Low iCVH 1531 5.6 (0.3) 5.1-6.1 
0.006* High iCVH 938 4.5 (0.3) 4.0-5.1 
Exam 5 
Low iCVH 1446 4.9 (0.2) 4.4-5.4 
0.733 High iCVH 813 4.8 (0.3) 4.1-5.4 
Exam 6 
Low iCVH 1159 5.0 (0.3) 4.4-5.5 
0.106 High iCVH 896 4.3 (0.3) 3.8-4.9 
Exam 7 
Low iCVH 1083 4.8 (0.3) 4.3-5.3 
0.109 
High iCVH 717 4.1 (0.3) 3.5-4.7 
*P value computed from ttest, significant at α <0.05 
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CHAPTER 5 
DISCUSSION OF FINDINGS 
  The main aim of this study was to describe the familial or intergenerational clustering 
and relationship between parents-offspring iCVH and CVD DALYs. Chapter 5 presents the 
major findings of this dissertation study. An account of the importance of the findings as well 
as extrapolating the findings to similar previous studies is presented. Particular focus is given 
to results on familial aggregation or clustering of iCVH and CVD DALYs that were 
examined when Original and Offspring Cohorts had similar mean age distribution. Data 
analyzed were derived from an eligible sample of Original (n=2,734) and Offspring 
(n=3,492) Cohorts of FHS both with mean age at baseline of 43 years in both cohorts. Both 
cohorts were balanced for the proportion of women and men, though the proportion of 
women was slightly larger than the proportion of men. 
Summary of Major Findings 
 It was hypothesized that iCVH of a parent is a predictor for iCVH of the offspring 
and that attainment of higher levels of iCVH was associated with fewer CVD DALYs for 
both parents and offspring. This study showed that offspring iCVH were significantly 
linearly related to iCVH of parents at similar age. This study revealed that offspring of 
parents with ideal iCVH had increased odds of achieving “ideal” iCVH by up to four times 
compared with offspring of parents with “poor” iCVH. CVD DALYs were associated with 
lower levels of iCVH categories for both Original and Offspring Cohorts. Offspring of 
parents with high iCVH had lower mean CVD DALYs compared with offspring of parents 
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with low iCVH, indicating a desired intergenerational effect of parents’ transference of 
cardiovascular health benefits to their children.  
Interpretation and Significance of the Findings  
 To our knowledge, this is the first study that has investigated whether long term 
trends of how parental iCVH, as classified by AHA, are clustered with biological offspring 
who were examined at similar ages throughout most of the adult lifespan. The study adds 
new insights on the protective association of high iCVH on CVD DALYs, a desirable trait in 
individuals in a population and policy makers in behavioral medicine. We studied the 
association of iCVH metrics such as normal BMI, physical activity, healthy diet, non-
smoking, normal blood pressure, blood cholesterol and blood glucose. The study showed that 
a small proportion of individuals attained the recommended levels of iCVH in both Original 
and Offspring Cohorts. Most importantly, the attainment or lack of attainment of iCVH 
thereof followed similar patterns within paired parent-offspring dyads over identical life-time 
which indicates familial clustering of identical iCVH scores between parents and offspring.  
 Similarities of iCVH metrics within the family clusters (familial aggregation of 
iCVH) is significant in CVD epidemiology suggesting that CVD prevention efforts can yield 
positive results if implemented within family environments to strengthen CVD prevention 
efforts targeting parents and their children. As observed in this study, the seven iCVH were 
strongly associated with CVD DALYs for each cohort and at each exam cycle. Indeed, the 
higher the iCVH, the lower the CVD DALYs for the observed participants. This inverse 
relationship between iCVH and CVD DALYs for parents and offspring respectively shows 
that addressing health behaviors or risk factors could help increase CVD-free survival. It is 
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encouraging to note that higher iCVH scores of parents (either having “intermediate” or 
“ideal” iCVH scores) were positively related to similar higher iCVH among the offspring. 
This indicates that offspring could achieve higher iCVH if their parents achieved similar 
levels of iCVH. These findings are fundamental for promoting parental involvement in their 
offspring cardiovascular health. Efforts to track iCVH metrics are in line with the AHA’s 
2020 Impact Goals of improving cardiovascular health and reducing stroke mortality (AHA, 
2013). 
Evidence from Literature on Attainment of iCVH Metrics 
 This dissertation study revealed that participants of the Framingham Original and 
Offspring Cohorts had a very low prevalence of iCVH [i.e, attaining either all five (0.6-10% 
for both Cohorts) or all seven iCVH metrics (0% for both Cohorts) at recommended levels]. 
Despite several FHS cohort participants being born several decades ago, results of attaining 
ideal iCVH does not differ from those of the general American population in recent studies 
which have estimated that only small proportion of Americans (<2%) attain all seven iCVH 
metrics (AHA, 2017a). BMI was one of the iCVH metrics investigated. The mean BMI and 
AHA BMI categories revealed a consistent pattern suggesting offspring had a higher mean 
BMI and lower proportion attaining “ideal” category of BMI. There was a general tendency 
of mean BMI increasing with increasing age-group across exam cycles for each cohort. 
These findings are not surprising. Several studies have consistently shown that the general 
trend of BMI increased for all age groups since the 1960s to date (Centers for Disease 
Prevention and Control, 2016b) . As much as there was lack of data on national surveys on 
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BMI studies before 1960s (von Hippel & Nahhas, 2013), it is evident that overweight and 
obesity prevalence was notably lower than  current estimates.  
 In the current study, the prevalence of obesity (i.e. “poor” BMI category) at each 
exam cycle for parents and offspring was considerably lower (13-31%) than 2016 estimates 
(39.6%). Studies report that the high prevalence of obesity (including childhood obesity) is a 
recent phenomenon starting in the early1990s where prevalence of adult obesity among the 
U.S population rose from 13.4% in 1960s to 30.5% in 1999 and 39.6% in 2016 (Centers for 
Disease Prevention and Control, 2016b). Notably, there has been an upward shift in 
socioeconomic status since the 1960s. Original Cohort participants had lower levels of 
educational attainment than the Offspring Cohort as shown Table 1; a huge shift reflecting 
the social structure then when most mothers did not work outside of the home. Parents had 
lower socioeconomic status (SES) than offspring as evidenced by high proportion having low 
cadre jobs (Table 1). A possible explanation why a larger proportion of FHS Original Cohort 
participants achieved “ideal” BMI than the Offspring Cohort could be that Offspring Cohort 
had a higher SES than their parents. Studies have shown that up to mid-20th century in the 
US, being overweight was positively associated with wealth status. This association then 
could explain the lower proportion of Original Cohort attaining “ideal” BMI compared to 
Offspring Cohort.  This pattern has since shifted as demonstrated by Hruby and Hu (2015) 
who reported that individuals with lower SES had higher obesity rates compared to higher 
levels of SES (Hruby & Hu, 2015). 
 Analysis of blood pressure shown in Table 4.3 revealed striking differences between 
the proportions of parents and Offspring Cohort with high blood pressure. Up to 37.9% (95% 
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CI: 36-40%) of parents in exam 1 had high blood pressure (SBP ≥140 or DBP ≥90mmHg 
“poor”) compared with only 17.6% (95% CI: 16-20%) offspring with high blood pressure 
even though blood pressure was assessed at exam cycles at which both cohorts had similar 
age. The proportion of parents with hypertension would even be higher for parents (>60%) if 
the current standards of hypertension (SBP≥130 or DBP≥80mmHg) were applied, but this 
criterion of hypertension was not in place during the Cohorts’ selected exam cycles. 
Attainment of most of the iCVH metrics at “ideal” levels declined with age, similar to the 
patterns observed in other observational studies showing that attainment of most ideal health 
factors especially blood pressure, glucose and cholesterol declined prominently with age 
(Shah et al., 2015). 
 Findings that offspring had lower proportions of high blood pressure are 
counterintuitive. It was expected that offspring would have higher blood pressure than the 
Original Cohort owing to epidemiological evidence suggesting that hypertension clusters 
within families and the risk of hypertension is higher for offspring of hypertensive parents 
genetic link and associated markers for hypertension (Andersson et al., 2016; Lieb Wolfgang 
et al., 2008). However, awareness, screening, diagnosis and treatment of hypertension has 
made major strides in the last 50 years, especially with the significant knowledge generated 
from the FHS. Since little was known about hypertension epidemiology in the 1950s 
(Dawber et al., 1951), it is expected that parents in the FHS would have higher blood 
pressure than their offspring regardless of whether offspring of parents with hypertension 
might have higher risk of having hypertension (Andersson et al., 2016; Lieb Wolfgang et al., 
2008). It is not surprising that the proportion of parents who smoked was higher than the 
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proportion among offspring (Table 4.6) in all exam cycles, and consequently conferring a 
higher risk of hypertension given that smoking is a significant risk factor for hypertension  
and  CVD (Messner Barbara & Bernhard David, 2014; Virdis, Giannarelli, Neves, Taddei, & 
Ghiadoni, 2010). It is established that adult prevalence of smoking in the 1950s (53%) to 70s 
(38%) was similar to the proportion of smoking among parents’ cohort (“poor” category) 
(Table 4.6). However, the prevalence of smoking declined significantly since 1970s 
(National Institutes of Health, 1979). In addition, similar patterns of declining prevalence of 
total cholesterol were observed. Parents had higher mean total cholesterol compared with the 
Offspring Cohort, i.e., a higher proportion [>40%] of Offspring Cohort achieved “ideal” 
levels of total cholesterol at all exam cycles compared with <40% among parents. These 
observations can be explained by higher risk factors for CVD among parents versus 
Offspring Cohort in the FHS which, as described above, could be attributed to poor 
awareness and treatment of CVD management in the early mid-20th century.  
 The prevalence of diabetes in both cohorts was low (0.7-8.8%) and increased with 
increasing age (i.e. at later exam cycles; Table 4.5). While this increase is to be  expected, 
offspring had significantly higher blood glucose than the parents in all exam cycles 
suggesting that there might have been amplified effects of offspring of parents with high 
blood glucose as revealed by Wang and Colleagues (2015) who found that parental history of 
diabetes was associated with presence of type 2 diabetes among the offspring (C. Wang et al., 
2015). Physical activity data available at two exam cycles showed that Original and 
Offspring Cohorts were more physically active at younger age, i.e. at earlier exam cycles, but 
the proportion of “ideal “activity levels declined with age as shown in Table 4.7. Notably, 
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FHS participants were more physically active compared with today’s standards (Shortreed et 
al., 2013). Diet data were the most intriguing amongst all other iCVH metrics. Parents’ diet 
data comprising of five food groups- fruits/vegetables, whole grains, nuts/legumes, low-fat 
milk/unsaturated fat, and meats/poultry, were collected later in the Original Cohort exam 
cycles not included in the analysis. However, we assumed that dietary patterns did not 
substantially change over time; thus, it was decided to include diet data not collected at the 
selected exam cycles. A review of multisite longitudinal and cross-sectional studies suggests 
that dietary patterns of individuals may not change so much with increasing age. Some 
studies suggest that individuals aged 65 years and older might have more healthy eating 
habits consisting of consuming less red meats, more fruits and vegetables than younger 
individuals (Produce for Better Health Foundation, 2015; Wakimoto & Block, 2001). While 
use of averaged diet variable at all exams cycles is justifiable, some studies suggest that older 
adults have reduced intake of  total energy and protein (Yannakoulia et al., 2018). 
 As expected from multiple studies on dietary patterns in the United States, vegetable 
and fruits intake “ideal” category was the least achieved metric in both Original and 
Offspring Cohorts. For instance, in 2007-2010, 76% and 87% of the US population did not 
meet recommended vegetable and recommended fruit consumption, respectively (Centers for 
Disease Prevention and Control, 2015b). More than 98% of FHS participants did not meet 
recommended vegetable and fruits consumption (Table 4.8). Other studies found that poor 
diet is attributable to the low attainment of iCVH in children and adults in the US (American 
Heart Association, 2017c).  Not achieving ideal diet score in both Cohorts (Table 4.9) is 
comparable to findings in other studies which showed consistently very low (<1%) 
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attainment of the seven iCVH metrics at “ideal” levels (American Heart Association, 2018b; 
Folsom et al., 2011). 
Attainment of Ideal Cardiovascular Health and Familial Aggregation  
 There is evidence that the proportion attaining all the seven iCVH metrics is 
extremely low in US adult and children. This dissertation examined the proportion attaining 
all seven and five iCVH metrics for parents and offspring separately. While no participant in 
any cohort attained all the seven iCVH at “ideal” levels, the proportion achieving all five 
recommended iCVH metrics at ideal levels was higher among the Offspring than the Original 
Cohort (for instance, 9.2% vs. 2.1%, p<0.001, first paired exam cycle). This finding is not 
surprising since most studies have shown that less than 2% of the US population meet all 
seven iCVH metrics at the “ideal” levels (American Heart Association, 2017c; Folsom et al., 
2011; Shah et al., 2015; Yang et al., 2012). A study of 12,744 participants aged 45-65 years 
estimated iCVH of participants in 1987 to 1989 using Atherosclerosis Risk in Communities 
Study cohort reported that a very small proportion, (0.1%) of the participants, met the seven 
iCVH metrics (Folsom et al., 2011). Using data from NHANES 2013-2014, the AHA 
reported even lower iCVH attainment with a negligible proportion of US adults attaining 
seven iCVH at “ideal” levels (American Heart Association, 2017c). Other studies looking at 
trends have shown that iCVH is declining in most US adults although some studies reported 
small increases (Ogunmoroti et al., 2016; Yang et al., 2012). Trends of iCVH between 2011 
and 2014 among employees of a large health care organization in South Florida (n=34,746)  
showed improvement in diet, physical activity, and blood pressure but a decline in BMI, total 
cholesterol, and blood glucose (Ogunmoroti, et al, 2016). That study revealed small increase 
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in “ideal” iCVH ranging from 0.3% in 2011 to 0.6% in 2014, [p<0.001] (Ogunmoroti et al., 
2016).  
 Correlation and regression analysis of familial aggregation of iCVH for paired 
parents and offspring revealed a positive linear relationship between Offspring Cohort iCVH 
with those of the Original Cohort using five-iCVH metric score (Table 4.13, 4.14), 
suggesting presence of familial clustering of iCVH. Patterns of achieving “poor”, 
“intermediate” and “ideal” iCVH score were similar in each cohort (Table 4.10) whether 
using five-or seven-iCVH metrics, a finding that shows that iCVH is clustered within 
families and that parents may influence their offspring attainment of iCVH. A matrix of 
Pearson correlations of parents and offspring iCVH over the exam cycles revealed positive 
correlations coefficients ranging between r=0.2 and r=0.3. Similar correlation coefficients 
were observed when the Offspring Cohort was correlated with mothers and fathers separately 
(Table 4.13). The linear correlations observed are similar to linear correlations observed in 
other studies which reported parent-offspring correlations coefficients ranging from r=0.24 to 
r=0.52 for single iCVH metrics such as diet, physical activity. There are no studies which 
assessed correlations coefficients for all five or seven iCVH metrics (McGowan et al., 2013; 
Storti, Kristi Leigh, 2007; Y. Wang, Beydoun, Li, Liu, & Moreno, 2011; Yee, Lwin, & Ho, 
2017). 
 Comparison of findings for correlations analysis and multivariate linear regressions 
yielded similar patterns for parent-offspring iCVH associations. Proportional odds regression 
analysis using the AHA classification of iCVH metrics (“poor”, “intermediate”, “ideal”) 
revealed that parental iCVH was associated with a two-to-fourfold the odds for attaining 
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“intermediate” or “ideal” iCVH levels in the Offspring Cohort, suggesting, as has been 
shown in other studies, that parents influence the health of their offspring. This finding is 
consistent with the evidence showing that the CVD health of parents and offspring are 
intricately associated (Vedanthan et al., 2016). It was also intriguing to note that relative to 
mothers, the iCVH for fathers at older ages had a larger effect on the Offspring Cohort iCVH 
metrics, whereas the iCVH for mothers had strongest effect on the Offspring iCVH at 
younger ages. However, it is important to note that this dissertation did not examine the 
iCVH for Offspring Cohort in childhood; an age range during which the mothers are likely to 
have stronger effect on offspring health habits (Dhana et al., 2018; Lawlor et al., 2007). The 
FHS was not designed to collect data for either parents or offspring during their early 
childhood years. Furthermore, in this analysis the mean age for Offspring Cohort at first 
eligible exam cycle (Exam 2) was 40 years. 
 Very minimal data exist on comparisons of paternal-offspring versus maternal-
offspring iCVH differences. A population-based study in Norway (Hunt Study n=36, 538 of 
father-mother-offspring trios) compared CVD risk factors of offspring and their parents  and 
found positive parent-offspring correlation with respect to blood pressure, blood lipids and 
glucose and resting heart rate (Vik, Romundstad, Carslake, Smith, & Nilsen, 2014). An 
important question to ask here is which parent (mother or father) would strongly influence 
offspring iCVH of their offspring, for instance if mothers influence would be stronger while 
in utero or fathers through genetic effects or the influence is mainly due to epigenetic effects. 
Epigenetic effects in offspring are known to be caused by shared family environment and 
lifestyle while some maternal-offspring theories such as the fetal overnutrition hypothesis, 
though contradictory, postulates that mothers directly influence fetal environment including 
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predisposition of offspring to CVD (Lawlor et al., 2007; Veena, Krishnaveni, Karat, 
Osmond, & Fall, 2013). The design of FHS could not establish intergenerational transmission 
of iCVH due to fetal overnutrition or exposure to other adverse factors in the intrauterine 
environment since maternal and paternal factors were not measured during or anytime close 
to pregnancy. In addition, most familial studies support shared family environment, lifestyle 
and epigenetic factors for parent-offspring CVD risk (Veena et al., 2013).   
 There is growing scientific evidence suggesting parent-offspring linear correlations of 
CVD risk factors such as BMI, physical inactivity and poor diet (Fuemmeler et al., 2011; 
Johnson et al., 2012; Massarani et al., 2015). This evidence, combined with findings from 
other studies, that suggest that development of atherosclerotic and hypertensive processes 
start early in life (Hayman & Worel, 2015; Juonala et al., 2010; Loria et al., 2007) 
underscoring the need for increased  studies focusing on familial iCVH over the lifespan. As 
explained above, the pathway for parent-offspring CVD is complex. Socioeconomic factors 
such as parental education and household income have been shown to effect that pathway 
(Martin et al., 2015).  Parental and/or individual offspring attainment of higher education and 
income,  have been shown to be associated with  favorable health outcomes throughout the 
life course (P. A. Braveman et al., 2010, 2011; P. Braveman et al., 2011). Results of this 
study point to some influence of socioeconomic factors on iCVH. Father-offspring clustering 
of iCVH was found to be more robust than clustering for mother-offspring dyads. While 
household income is inseparable within family units, it was observed that fathers were more 
educated and with a higher income than their mothers. Epidemiological studies that measure 
childhood socioeconomic status often use fathers’ education as the proxy for the childhood 
socioeconomic status and observe that parental socioeconomic status is an important 
 97 
 
predictor of offspring CVD (Galobardes, Lynch, & Smith, 2008; Loucks et al., 2009). To 
demonstrate the robustness of parental education in intergenerational transfer of health, a 
study involving 1480 parent-offspring  dyads in Netherlands  revealed that higher parental 
educational attainment was associated with healthier family clusters, with notable 
improvements in physical activity and healthy diet (Rodenburg et al., 2013). In this 
dissertation, it was hypothesized that parental education was the main predictor for 
intergenerational transmission of iCVH from parents to offspring. 
Relationship Between CVD DALYs and iCVH  
 The health benefits to the individual for attaining iCVH should not be 
underestimated. Several studies continue to provide evidence that having certain iCVH 
metrics such as consumption of healthy diet, engaging in physical exercise, not smoking  
throughout lifespan can  promote longevity and morbidity-free survival, health-related 
quality of life even in old age, and lower costs of healthcare in old age (Chakravarty et al., 
2012; Hozawa et al., 2007);  A Taiwan longitudinal study of men and  women aged 60 years 
and older showed that the combined effect of health factors on functional disability attributed 
to one or more healthy behaviors contributed 15% to 75% reduction in functional disability 
(Liao et al., 2011) while another study on participants aged 65 years of age had 8.3 years 
delayed onset of moderate disability (Chakravarty et al., 2012). In the Atherosclerosis Risk in 
Communities (ARIC) study with four combined health factors (total cholesterol, blood 
pressure, no diabetes and never smoked) documented that participants with optimum 
combined health factors were 88% less likely to die due to CVD (HR 0.12, 95% CI 0.04-
0.31) compared with those with any elevated risk factors (Hozawa et al., 2007). Another 
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study designed  to evaluate the relationship between iCVH score and CVD biomarkers 
among the FHS Offspring Cohort concluded that participants with higher iCVH score had 
more favorable CVD biomarkers such as higher circulating concentrations of natriuretic 
peptides (Xanthakis et al., 2014). The study also found an inverse relationship between iCVH 
and subclinical disease, where those with higher iCVH score had a lower risk of CVD. All 
these studies support the premise that iCVH score if favorable for increasing CVD-free life 
span and reduction of CVD risk. 
 Results of CVD burden in this study was reported as number of CVD events per 
exam cycle and CVD DALYs for a fixed period for parents and offspring. The incidence of 
CVD events for parents were higher than their offspring (see Table 4.11). It was expected 
that the offspring would have equal or higher proportion of CVD events than their parents. 
However, it is notable that FHS parents lived as adults during a period when cardiovascular 
medicine had just started to receive more attention. In fact, the rise of CVD prevalence in the 
US during early 20th century necessitated National Heart, Lung and Blood Institute to design 
and establish the FHS, a location at which they previously had conducted a successful 
Tuberculosis screening project (Matson, 1924). There were limited scientific studies on the 
diagnosis and treatment of heart disease and other CVDs in early 1900s to 1950s. Coronary 
atherosclerosis was the leading cause of unprecedented coronary heart disease mortality with 
prevalence of coronary atherosclerosis up to 77% in 1950 (Dalen, Alpert, Goldberg, & 
Weinstein, 2014). During that period, CVD was diagnosed using autopsies because CVD was 
often not assessed or detected and treated during ones’ life due to lack of sophisticated 
technology currently used to diagnose and treat CVD. The Surgeon General’s report in 1950 
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reported that the prevalence of cigarette smoking,  major risk factor for CVD, peaked at 53% 
(Dalen et al., 2014; National Institutes of Health, 1979). It would therefore be expected that 
FHS Original Cohort (parents) which was recruited in 1948, a period with high prevalence of 
undiscovered CVD risk factors such as smoking and coronary atherosclerosis would 
consequently have a higher CVD incidence than Offspring Cohort participants who enjoyed a 
more advanced CVD management. 
 The follow-up period for estimating CVD DALYs for both Cohorts extends over a 
longer time period than the selected iCVH exam cycles to obtain a longer follow-up time of 
43 years. The events follow-up period of 43 years was used since the events files had CVD 
events recorded up to the year 2014. Most of the parents' life expectancy was considerably 
longer than the current life expectancy for (81 years for females and 76 years for males). 
According to trend data on US life expectancy (National Center for Health Statistics, 2018), 
the life expectancy of  persons born in 1900, such as the FHS parents cohort was 47.3 years 
meaning by 1948, about half of the Framingham sample should have been dead and 
presumably could not join the study. The mean age of this initial Exam 1 group of 5209 was 
44 years, producing a mean birth year of 1906. It is possible the original estimates of life 
expectancy in 1900s were inaccurate given that most of the Framingham subjects were still 
alive, having survived all the natural and manmade disasters and disease outbreaks that had 
occurred. This informed the decision not to use life expectancies of 1900s and use the current 
2016 across the board for parents and offspring, so that the cohorts’ DALYs could be 
compared with DALYs calculated from recent data.  
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 The burden of CVD as was measured using CVD DALYs. Results suggest that for 
both parents and the offspring, iCVH was significantly negatively associated with CVD 
DALYs. This association was found at most of the exam cycles. This finding was expected 
since, as explained earlier in the discussion section, combination of healthy factors are 
negatively associated with incident CVD and CVD mortality over lifespan (Akesson et al., 
2007; Hozawa et al., 2007; Ogunmoroti et al., 2017). Overall, offspring had higher CVD 
DALYs rate per 100, 000 population compared with parental rate (offspring had 550, 273 
CVD DALYs vs.176, 564 for parents). Compared with a recent study, these rates are much 
lower than estimates from the Global Burden of Disease which showed Texas had the highest 
CVD DALYs rate of 874, 588 DALYs in 1990 (2018 Global Burden of Cardiovascular 
Diseases Collaboration et al., 2018).  The mean age of onset of CVD disease for most parents 
was higher for parents than offspring. This possibly indicates why offspring had higher CVD 
DALYs even though they had fewer number of CVD events overall since DALYs are usually 
driven by the number of years someone lives with a condition or dies prematurely. However, 
the main differences in CVD DALYs rates for FHS participants and the US GBD study are 
not comparable since the study was conducted non-contemporaneously versus the FHS 
(1990-2016 for US GBD study vs. 1948-2014 for FHS). FHS participants lived in a period 
when CVD morbidity and mortality was higher than recent and current trends. It is important 
to also note that both Cohorts did not receive identical CVD treatment or care at the exam 
cycles studied. This could possibly explain some of the differences in the CVD DALYs. 
Interestingly, most of the parents in the FHS, by a huge margin, outlived the prevailing the 
life expectancy of their time of 47 years for1900 and 68.2 years for 1950 (Health, United 
States, 2016). This phenomenon whereby a substantial proportion of parents in FHS outlived 
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the expected life expectancy of 81 years for women and 76 years for men has been reported 
elsewhere (Terry et al., 2007). In that 2007 study of 1697 offspring, the proportion with one, 
or both parents surviving to 85 years or older was 47%, and 11%, respectively. In the current 
study, however, there was no way to account for non-overlapping of treatment and care of 
CVD in exam periods that were not at the same time, and the effects due to aging of the 
cohort with added benefits of receiving advanced cardiovascular care that was not 
comparable to the population not in the FHS. 
 One of the possible explanations the FHS Original Cohort had longer than expected 
life expectancy or had lower CVD DALYs compared with the general population, as noted 
above, might be due to age-period-cohort effects. Age effects refer to the changes that are 
bound to happen as individual progresses through their life course; cohort effects refer to 
changes of health status of a society especially due to new interventions and period effects 
refer to changes in health care by the virtue of lapse in time (Burton-Jeangros, Cullati, & 
Sacker, 2015). It is expected that age-period-cohort effects serve as potential confounders for 
an intergenerational study such as FHS. The confounding is influenced via socioeconomic 
shifts and medical discoveries and other historical and health-related events such as obesity 
epidemic or disease outbreaks that could potentially contribute to either optimal or 
suboptimal cardiovascular health over time.  Statistically accounting for age-period-cohort 
effects is difficult to implement, in fact, many authors cast fundamental doubts on robustness 
and accuracy of various methods proposed to address age-period-cohort effects (Bell & 
Jones, 2013; Burton-Jeangros et al., 2015). 
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 Findings of this dissertation support that development of CVD is multifactorial 
characterized by interplay of genetic, genomic and environmental factors (Vedanthan et al., 
2016). Unlike single-gene disorders such as cystic fibrosis or sickle-cell disease, CVD 
manifests as polygenic or multiple-gene disorder. Genome-wide studies have shown that 
10% of the variation of CVD disorders like coronary artery disease is genetic (Bjorkegren, 
Kovacic, Dudley, & Schadt, 2015). Studies have established that polygenic disorders like 
CVD are significantly affected by complex interactions of both genetic and potentially 
modifiable environmental factors (Bjorkegren et al., 2015). These studies report that more 
than 90% of remaining hereditability of polygenic disorders would be explained by certain 
environmental factors, a concept known as systems genetics which integrates genomic 
measures such as DNA, clinical measures such as blood chemistry and environmental factors 
such as health behaviors (Vedanthan et al., 2016). Thus said, systems genetics provides an 
advantage of assessing the combined effects of genetics and environmental factors in disease 
pathways.  
 The Family Systems Theory is the conceptual model used in this dissertation. Family 
Systems Theory addresses the two main tenets of systems genetics (clinical measures and 
environmental factors), which explain a substantial variance of offspring CVD DALYs even 
in this study. This theory has been used to study intergenerational transfer of iCVH health 
from parents to offspring, in the understanding of interplay of clinical and environmental 
factors. The family-systems model, as explained in the methods sections, was triangulated 
with self-care theory of multiperson units which means that family units are viewed as 
systems (multiperson units) for interactions to yield certain behaviors that lead to healthy or 
unhealthy outcomes. Principles of self-care theory for individuals’ deliberately actions to meet 
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their own health goals can be applied to enhance systems theory in sustaining the acquired 
health behaviors over time (Geden & Taylor, 1999; Taylor, 2001). Very low prevalence of 
iCVH scores for both parents and offspring, positive linkage of iCVH and CVD DALYs 
emphasize the importance of implementing family-oriented interventions specifically 
targeting combined iCVH metrics. 
Limitations and Strengths  
 This dissertation study has several limitations related to the contemporaneousness of 
the ages of the Original and the Offspring Cohorts at the selected exam cycles. Firstly, it was 
not possible to compare Original and Offspring Cohorts when they were younger than 20 
years old, or parents at child rearing years, and offspring’s childhood behavioral patterns. It 
was assumed that such behavioral interactions of parents and offspring during childhood 
years would persist in adulthood. However, a study involving younger than 20 years of age 
would not generate enough CVD events for investigating the role of iCVH on CVD over 
time. Secondly, unavailability of data on two key variables, physical activity (only available 
2 exam for each cohort) and dietary data (3 exam cycles available for Original Cohort outside 
the matched exam cycle time-period) was a major limitation for deriving 7-metric iCVH. 
Third, FHS Original and the Offspring Cohorts samples were recruited from a single 
geographic location of principally middle-class, white individuals hence it is not possible to 
study racial differences. However, the FHS setting does include several widely separated 
areas simultaneously, so that the various socioeconomic groups were represented hence 
includes participants with both high and low SES (Northwestern University, 2013; Tsao & 
Vasan, 2015). In addition, FHS has contributed to science that is applicable among diverse 
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multiethnic groups and some of the findings such as CVD risk factors are similar to other 
multiethnic cohort studies (Tsao & Vasan, 2015). Other limitations include inability to 
account for other factors in the built and social environment and social desirability associated 
with self-reported behaviors. 
 There are several strengths associated with this study. Specifically, it is noteworthy 
that the FHS has made major contributions to the science of CVD prevention and 
management and was implemented in a period when epidemiological research was not 
advanced, lacked the modern comforts of technology and medical inventions. The 
longitudinal nature of FHS and follow up of participants up to 43 years is helpful to reveal 
temporal trends of iCVH and CVD. The extended follow up made it possible to observe 
intergenerational iCVH differences for parents and offspring at similar age in lifespan. This 
study therefore unveils systematic iCVH patterns of parents and their offspring over a 
defined life span. Prospective cohort study designs such as the FHS are important to 
determine the temporal sequence, examine multiple disease outcomes and calculate incident 
rates over time (Song & Chung, 2010). More importantly, the FHS has pioneered efforts to 
collect data on the relationship between parental and offspring CVD. In this dissertation we 
optimized data from two Framingham cohorts, treating the Offspring Cohort as children of 
the Original Cohort.  The FHS, which was designed to determine “expression” or “natural 
history” of CVD in a free-living, community population provides a unique opportunity and 
high-quality data to longitudinally examine these questions. The study setting is a stable, 
well-characterized population. During the adjudication process in the FHS, the underlying, 
immediate, and contributing causes of death are determined. The CVD events files 
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meticulously records diagnoses as they occur among participants. Disease conditions are 
systematically coded using an expanded ICD-9 coding system. The CVD outcomes are 
adjudicated by a 3-physician panel. The adjudication process limits chances for 
misclassification. 
Conclusion and Implications 
  This dissertation has elucidated the relationship between parents and offspring’s 
iCVH and how this relationship can be used for advancing CVD risk reduction strategies. 
Since CVD is a complex disease involving genomic measures such as DNA, clinical 
measures such as blood chemistry and environmental factors, systems approach to 
implementation of family-based interventions have potential to increase the information yield 
through examination of the combined effect of modifiable clinical, behavioral and 
environmental factors in CVD disease pathways. This study highlights the role of individuals 
to self-manage their cardiovascular health given the importance of attaining ideal iCVH, as 
well as the role of policies in addressing key barriers of attaining ideal iCVH.  
 It is evident that clinicians spend very little time with their clients in one’s life span. 
Thus, emphasis has been placed on efforts to develop individually-tailored, self-sustaining 
interventions that address specific health needs of different individuals in a population, given 
different health needs as well as resources of different people. It is well-established that 
individuals benefit from close associates in attempts to achieve ideal heart health; hence, 
feasible family-based approaches need to be developed to support primary prevention efforts. 
These efforts need to be intensified with increasing focus such as is devoted to other 
secondary prevention efforts as well as integrating health promotion interventions that 
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achieve similar objectives. It is clear that policies like smoking cessation implemented in the 
1960s, as demonstrated in this study, helped reduce incident CVD. These trends of CVD risk 
factors tell an important story that if a positive health intervention is implemented, long term 
health effects may be realized, some of which may be intergenerational health benefits. There 
is a dire need for policies that support primordial CVD prevention efforts, designed to 
prevent the development of the risk factor in the first place.  Such policies would address 
improving access to healthy food and physical activity environments for children, 
adolescents and adults. With emphasis on promoting ideal cardiovascular health for all, such 
policies would enable provision of healthy, nutrient rich food to families, particularly for 
those who live in marginalized communities. Other policies might include access to built 
environments conducive to physically active lifestyles with play/recreational spaces.  These 
measures will be acting synergistically to enhance achievement of most of the iCVH metrics. 
Findings that parents influence their children’s attainment of iCVH, reduce CVD DALYs 
and that iCVH is clustered within families provides health policy makers with the needed 
actionable information to inform the discussion on optimal allocation of resources to family-
based primordial CVD prevention programs. Future research should involve longitudinal 
follow up of units of families with particular emphasis on nutrition and physical activity data 
and examine the magnitude of each iCVH metric’s contribution to cardiovascular health and 
CVD DALYs for individuals of the same family.  
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APPENDIX 
A. ANNUAL PERSONAL INCOME IN $ FOR OFFSPRING  
Income n% Male  (n% ) Female (n%) p value 
 No Income 132 (6.4) 8 (0.8) 124 (11.9) 
0.000 
≤ $19,000 715 (34.4) 146 (14.1) 569 (54.5) 
$20,000 TO $39,000 841 (40.5) 535 (51.7) 306 (29.3) 
≥ $40,000 390 (18.7) 345 (33.4) 45 (4.3) 
P value for t-test for male and female personal income, Exam 3, 1983-1987  
 
B. GROUPED AGE FOR EACH COHORT BY EXAM CYCLE 
Exam Sex n 25-34 35-44 45-54 55-64 65+ P value n 25-34 35-44 45-54 55-64 65+ P value
Exam 1/2 Male 1290 185 (14.3) 507 (39.3) 417 (32.3) 181 (14.0) 0 (0.0) 1246 289 (23.2) 421 (33.8) 352 (28.3) 173 (13.9) 11 (0.9)
Female 1347 243 (18.0) 552 (41.0) 403 (30.0) 149 (11.1) 0 (0.0) 1371 300 (21.9) 443 (32.3) 405 (29.5) 209 (15.4) 14 (1.0)
Exam 3/3 Male 1134 17 (1.5) 442 (39.0) 370 (32.6) 300 (26.5) 5 (0.4) 1247 137 (11.0) 419 (33.6) 358 (28.7) 297 (23.8) 36 (2.9)
Female 1207 20 (1.7) 519 (43.0) 398 (33.0) 255 (21.1) 15 (1.2) 1364 127 (9.3) 436 (32.0) 415 (30.4) 330 (24.2) 56 (4.1)
Exam 5/4 Male 1131 0 (0.0) 278 (24.6) 440 (39.0) 316 (28.0) 97 (8.6) 1285 80 (6.2) 345 (26.9) 416 (32.4) 330 (25.7) 114 (8.9)
Female 1234 0 (0.0) 357 (29.0) 458 (37.1) 341 (27.6) 78 (6.3) 1401 66 (4.7) 371 (26.5) 428 (30.6) 397 (28.3) 139 (9.9)
Exam 7/5 Male 1065 0 (0.0) 88 (8.3) 442 (41.5) 345 (32.4) 190 (17.8) 1196 31 (2.6) 209 (17.3) 429 (38.9) 338 (28.3) 189 (15.8)
Female 1210 0 (0.0) 112 (9.3) 540 (44.6) 383 (31.7) 175 (14.5) 1359 20 (1.3) 234 (15.4) 509 (33.5) 437 (28.8) 320 (21.1)
Exam 9/6 Male 987 0 (0.0) 2 (0.2) 357 (36.2) 351 (35.6) 277 (28.1) 1104 0 (0.0) 111(10.1) 366 (33.2) 356 32.3) 271 (24.6)
Female 1149 0 (0.0) 2 (0.2) 451 (39.3) 402 (35.0) 294 (25.6) 1262 0 (0.0) 109 (8.8) 393 (31.1) 386 (30.6) 374 (29.6)
Exam11/7 Male 771 0 (0.0) 0 (0.0) 148 (19.2) 336 (43.6) 287 (37.2) 1113 0 (0.0) 59 (5.3) 284 (25.5) 395 (35.5) 375 (33.7)
Female 937 0 (0.0) 0 (0.0) 199 (21.2) 405 (43.2) 333 (35.5) 1299 0 (0.0) 44 (3.4) 333 (25.6) 418 (32.2) 375 (33.7)
0.453
0.546
0.687
0.217
0.192
0.178
0.002
0.013
0.110
0.008
0.008
0.033
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C. NUMBER OF INCLUDED AND MISSING PARTICIPANTS FOR 5-ICVH METRICS 
1 Missing values for blood sugar for parents and offspring  
Original Cohort Offspring Cohort 
Exam 
# 
included 
# BG 
missing 
% BG 
missing 
# BG 
nonmissing Exam 
# 
included 
# BG 
missing 
% BG 
missing 
# BG 
nonmissing 
Exam 
1 2637 61 2.3 2576 
Exam 
2 2617 108 4.1 2509 
Exam 
3 2341 37 1.6 2304 
Exam 
3 2631 194 7.4 2437 
Exam 
5 2365 78 3.3 2287 
Exam 
4 2686 205 7.6 2481 
Exam 
7 2275 75 3.3 2200 
Exam 
5 2555 66 2.6 2489 
Exam 
9 2136 41 1.9 2095 
Exam 
6 2366 91 3.8 2275 
Exam 
11 1708 35 2.0 1673 
Exam 
7 2412 184 7.6 2228 
2. Missing values for BMI for parents and offspring 
Original Cohort  Offspring Cohort 
Exam 
# 
included 
# BMI 
missing 
% BMI 
missing 
# BMI 
nonmissing Exam 
# 
included 
# BMI 
missing 
% BMI 
missing 
# BMI 
nonmissing 
Exam 
1 2637 3 0.1 2634 
Exam 
2 2617 1 0.0 2616 
Exam 
3 2341 3 0.1 2338 
Exam 
3 2631 49 1.9 2582 
Exam 
5 2365 9 0.4 2356 
Exam 
4 2686 14 0.5 2672 
Exam 
7 2275 65 2.9 2210 
Exam 
5 2555 21 0.8 2534 
Exam 
9 2136 66 3.1 2070 
Exam 
6 2366 35 1.5 2331 
Exam 
11 1708 25 1.5 1683 
Exam 
7 2412 131 5.4 2281 
3. Missing values for blood cholesterol for parents and offspring 
Original Cohort  Offspring Cohort  
Exam 
# 
included 
# CHOL 
missing 
% CHOL 
missing 
# CHOL 
nonmissing Exam 
# 
included 
# CHOL 
missing 
% CHOL 
missing 
# CHOL 
nonmissing 
Exam 
1 2637 70 2.7 2567 
Exam 
2 2617 5 0.2 2612 
Exam 
3 2341 30 1.3 2311 
Exam 
3 2631 89 3.4 2542 
Exam 
5 2365 28 1.2 2337 
Exam 
4 2686 71 2.6 2615 
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Exam 
7 2275 24 1.1 2251 
Exam 
5 2555 20 0.8 2535 
Exam 
9 2136 18 0.8 2118 
Exam 
6 2366 34 1.4 2332 
Exam 
11 1708 35 2.0 1673 
Exam 
7 2412 133 5.5 2279 
          
4. Missing values for blood pressure for parents and offspring 
Original Cohort  Offspring Cohort  
Exam 
# 
included 
# BP 
missing 
% BP 
missing 
# BP 
nonmissing Exam 
# 
included 
# BP 
missing 
% BP 
missing 
# BP 
nonmissing 
Exam 
1 2637 0 0.0 2637 
Exam 
2 2617 0 0.0 2617 
Exam 
3 2341 0 0.0 2341 
Exam 
3 2631 0 0.0 2631 
Exam 
5 2365 0 0.0 2365 
Exam 
4 2686 0 0.0 2686 
Exam 
7 2275 0 0.0 2275 
Exam 
5 2555 0 0.0 2555 
Exam 
9 2136 0 0.0 2136 
Exam 
6 2366 1 0.0 2365 
Exam 
11 1708 12 0.7 1696 
Exam 
7 2412 4 0.2 2408 
5. Table of missing values for smoking for parents and offspring 
Original Cohort Offspring Cohort  
Exam 
# 
included 
# SMK 
missing 
% SMK 
missing 
# SMK 
nonmissing Exam 
# 
included 
# SMK 
missing 
% SMK 
missing 
# SMK 
nonmissing 
Exam 
1 2637 18 0.7 2619 
Exam 
2 2617 0 0.0 2617 
Exam 
4 2341 125 5.3 2216 
Exam 
3 2631 3 0.1 2628 
Exam 
5 2365 4 0.2 2361 
Exam 
4 2686 7 0.3 2679 
Exam 
7 2275 42 1.8 2233 
Exam 
5 2555 3 0.1 2552 
Exam 
9 2136 0 0.0 2136 
Exam 
6 2366 8 0.3 2358 
Exam 
11 1708 19 1.1 1689 
Exam 
7 2412 4 0.2 2408 
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